USRE33635E - Enzymatic assay method - Google Patents
Enzymatic assay method Download PDFInfo
- Publication number
- USRE33635E USRE33635E US07/203,071 US20307188A USRE33635E US RE33635 E USRE33635 E US RE33635E US 20307188 A US20307188 A US 20307188A US RE33635 E USRE33635 E US RE33635E
- Authority
- US
- United States
- Prior art keywords
- compound
- amino
- assay
- assay method
- asod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 79
- 238000007824 enzymatic assay Methods 0.000 title description 3
- 238000003556 assay Methods 0.000 claims abstract description 109
- 239000000049 pigment Substances 0.000 claims abstract description 103
- 238000010521 absorption reaction Methods 0.000 claims abstract description 99
- -1 amino, substituted amino, hydroxy, carboxyl Chemical group 0.000 claims abstract description 92
- 150000001875 compounds Chemical class 0.000 claims abstract description 84
- 238000006243 chemical reaction Methods 0.000 claims abstract description 42
- 229910052739 hydrogen Chemical group 0.000 claims abstract description 33
- 239000001257 hydrogen Chemical group 0.000 claims abstract description 33
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 30
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 24
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 23
- 239000001301 oxygen Substances 0.000 claims abstract description 23
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 22
- 238000005259 measurement Methods 0.000 claims abstract description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 10
- 150000002367 halogens Chemical class 0.000 claims abstract description 10
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims abstract description 10
- 238000007398 colorimetric assay Methods 0.000 claims abstract description 7
- 239000000758 substrate Substances 0.000 claims description 109
- 108010029541 Laccase Proteins 0.000 claims description 35
- 102000004316 Oxidoreductases Human genes 0.000 claims description 30
- 108090000854 Oxidoreductases Proteins 0.000 claims description 30
- 102000004157 Hydrolases Human genes 0.000 claims description 29
- 108090000604 Hydrolases Proteins 0.000 claims description 29
- 108091005804 Peptidases Proteins 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 16
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 16
- 102000035195 Peptidases Human genes 0.000 claims description 15
- 108090000765 processed proteins & peptides Chemical group 0.000 claims description 13
- 108090000371 Esterases Proteins 0.000 claims description 12
- 108090001060 Lipase Proteins 0.000 claims description 12
- 102000004882 Lipase Human genes 0.000 claims description 12
- 239000004367 Lipase Substances 0.000 claims description 12
- 230000009471 action Effects 0.000 claims description 12
- 235000019421 lipase Nutrition 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 10
- 102000003425 Tyrosinase Human genes 0.000 claims description 10
- 108060008724 Tyrosinase Proteins 0.000 claims description 10
- 235000019419 proteases Nutrition 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- 108010024957 Ascorbate Oxidase Proteins 0.000 claims description 8
- 238000009833 condensation Methods 0.000 claims description 8
- 230000005494 condensation Effects 0.000 claims description 8
- 230000002255 enzymatic effect Effects 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 235000019833 protease Nutrition 0.000 claims description 8
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims description 7
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims description 7
- 125000000539 amino acid group Chemical group 0.000 claims description 7
- 230000001590 oxidative effect Effects 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- NFGODEMQGQNUKK-UHFFFAOYSA-M [6-(diethylamino)-9-(2-octadecoxycarbonylphenyl)xanthen-3-ylidene]-diethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C1=C2C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C21 NFGODEMQGQNUKK-UHFFFAOYSA-M 0.000 claims description 3
- KCNKJCHARANTIP-SNAWJCMRSA-N allyl-{4-[3-(4-bromo-phenyl)-benzofuran-6-yloxy]-but-2-enyl}-methyl-amine Chemical compound C=1OC2=CC(OC/C=C/CN(CC=C)C)=CC=C2C=1C1=CC=C(Br)C=C1 KCNKJCHARANTIP-SNAWJCMRSA-N 0.000 claims description 3
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 2
- 125000001483 monosaccharide substituent group Chemical group 0.000 claims 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
- 125000005313 fatty acid group Chemical group 0.000 claims 2
- 101100177155 Arabidopsis thaliana HAC1 gene Proteins 0.000 claims 1
- 102100026189 Beta-galactosidase Human genes 0.000 claims 1
- 108010059881 Lactase Proteins 0.000 claims 1
- 101100434170 Oryza sativa subsp. japonica ACR2.1 gene Proteins 0.000 claims 1
- 101100434171 Oryza sativa subsp. japonica ACR2.2 gene Proteins 0.000 claims 1
- 229940116108 lactase Drugs 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 38
- 108090000790 Enzymes Proteins 0.000 abstract description 38
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 abstract 1
- 101150035983 str1 gene Proteins 0.000 abstract 1
- 208000026753 anterior segment dysgenesis Diseases 0.000 description 196
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 170
- HFYPXERYZGFDBD-UHFFFAOYSA-N 4-amino-2,6-dibromophenol Chemical compound NC1=CC(Br)=C(O)C(Br)=C1 HFYPXERYZGFDBD-UHFFFAOYSA-N 0.000 description 92
- 238000004737 colorimetric analysis Methods 0.000 description 73
- 239000008363 phosphate buffer Substances 0.000 description 64
- 239000000243 solution Substances 0.000 description 57
- NKTOLZVEWDHZMU-UHFFFAOYSA-N 2,5-xylenol Chemical compound CC1=CC=C(C)C(O)=C1 NKTOLZVEWDHZMU-UHFFFAOYSA-N 0.000 description 52
- QNGVNLMMEQUVQK-UHFFFAOYSA-N 4-n,4-n-diethylbenzene-1,4-diamine Chemical compound CCN(CC)C1=CC=C(N)C=C1 QNGVNLMMEQUVQK-UHFFFAOYSA-N 0.000 description 50
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 41
- 239000011591 potassium Substances 0.000 description 41
- 229910052700 potassium Inorganic materials 0.000 description 41
- SSIZLKDLDKIHEV-UHFFFAOYSA-N 2,6-dibromophenol Chemical compound OC1=C(Br)C=CC=C1Br SSIZLKDLDKIHEV-UHFFFAOYSA-N 0.000 description 38
- 229940088598 enzyme Drugs 0.000 description 37
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 35
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 33
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 29
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 28
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical compound COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 26
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 22
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 22
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 22
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 20
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 20
- 210000002966 serum Anatomy 0.000 description 20
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 19
- QWBBPBRQALCEIZ-UHFFFAOYSA-N 2,3-dimethylphenol Chemical compound CC1=CC=CC(O)=C1C QWBBPBRQALCEIZ-UHFFFAOYSA-N 0.000 description 19
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 19
- 229940018564 m-phenylenediamine Drugs 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 19
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 17
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 17
- 239000002158 endotoxin Substances 0.000 description 17
- 125000006239 protecting group Chemical group 0.000 description 15
- 108090000637 alpha-Amylases Proteins 0.000 description 14
- 102000004139 alpha-Amylases Human genes 0.000 description 14
- 229940024171 alpha-amylase Drugs 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- TUAMRELNJMMDMT-UHFFFAOYSA-N 3,5-xylenol Chemical compound CC1=CC(C)=CC(O)=C1 TUAMRELNJMMDMT-UHFFFAOYSA-N 0.000 description 13
- 239000004382 Amylase Substances 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 13
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 13
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 102000013142 Amylases Human genes 0.000 description 12
- 108010065511 Amylases Proteins 0.000 description 12
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 12
- 229910019142 PO4 Inorganic materials 0.000 description 12
- 108010028144 alpha-Glucosidases Proteins 0.000 description 12
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 12
- 235000019418 amylase Nutrition 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 239000010452 phosphate Substances 0.000 description 12
- 235000021317 phosphate Nutrition 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 11
- FAXWFCTVSHEODL-UHFFFAOYSA-N 2,4-dibromophenol Chemical compound OC1=CC=C(Br)C=C1Br FAXWFCTVSHEODL-UHFFFAOYSA-N 0.000 description 10
- MNVMYTVDDOXZLS-UHFFFAOYSA-N 4-methoxyguaiacol Natural products COC1=CC=C(O)C(OC)=C1 MNVMYTVDDOXZLS-UHFFFAOYSA-N 0.000 description 10
- QEZZCWMQXHXAFG-UHFFFAOYSA-N 8-aminonaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C(N)=CC=CC2=C1 QEZZCWMQXHXAFG-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- KUFFULVDNCHOFZ-UHFFFAOYSA-N 2,4-xylenol Chemical compound CC1=CC=C(O)C(C)=C1 KUFFULVDNCHOFZ-UHFFFAOYSA-N 0.000 description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 8
- DHYHYLGCQVVLOQ-UHFFFAOYSA-N 3-bromoaniline Chemical compound NC1=CC=CC(Br)=C1 DHYHYLGCQVVLOQ-UHFFFAOYSA-N 0.000 description 8
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 8
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 8
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 108010072542 endotoxin binding proteins Proteins 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- 229940018563 3-aminophenol Drugs 0.000 description 7
- 108090000631 Trypsin Proteins 0.000 description 7
- 102000004142 Trypsin Human genes 0.000 description 7
- 108010047754 beta-Glucosidase Proteins 0.000 description 7
- 102000006995 beta-Glucosidase Human genes 0.000 description 7
- 239000012588 trypsin Substances 0.000 description 7
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 6
- AKCRQHGQIJBRMN-UHFFFAOYSA-N 2-chloroaniline Chemical compound NC1=CC=CC=C1Cl AKCRQHGQIJBRMN-UHFFFAOYSA-N 0.000 description 6
- ZUVPLKVDZNDZCM-UHFFFAOYSA-N 3-chloro-2-methylaniline Chemical compound CC1=C(N)C=CC=C1Cl ZUVPLKVDZNDZCM-UHFFFAOYSA-N 0.000 description 6
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 6
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 240000007660 Sechium edule Species 0.000 description 6
- 235000019095 Sechium edule Nutrition 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 6
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 6
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 6
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
- KGEXISHTCZHGFT-UHFFFAOYSA-N 4-azaniumyl-2,6-dichlorophenolate Chemical compound NC1=CC(Cl)=C(O)C(Cl)=C1 KGEXISHTCZHGFT-UHFFFAOYSA-N 0.000 description 5
- GZFGOTFRPZRKDS-UHFFFAOYSA-N 4-bromophenol Chemical compound OC1=CC=C(Br)C=C1 GZFGOTFRPZRKDS-UHFFFAOYSA-N 0.000 description 5
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 102000004366 Glucosidases Human genes 0.000 description 5
- 108010056771 Glucosidases Proteins 0.000 description 5
- 101710135670 Putative Xaa-Pro dipeptidyl-peptidase Proteins 0.000 description 5
- 101710143531 Xaa-Pro dipeptidyl-peptidase Proteins 0.000 description 5
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 5
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 239000001110 calcium chloride Substances 0.000 description 5
- 229910001628 calcium chloride Inorganic materials 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 4
- SWFNPENEBHAHEB-UHFFFAOYSA-N 2-amino-4-chlorophenol Chemical compound NC1=CC(Cl)=CC=C1O SWFNPENEBHAHEB-UHFFFAOYSA-N 0.000 description 4
- ZMXYNJXDULEQCK-UHFFFAOYSA-N 2-amino-p-cresol Chemical compound CC1=CC=C(O)C(N)=C1 ZMXYNJXDULEQCK-UHFFFAOYSA-N 0.000 description 4
- MLPVBIWIRCKMJV-UHFFFAOYSA-N 2-ethylaniline Chemical compound CCC1=CC=CC=C1N MLPVBIWIRCKMJV-UHFFFAOYSA-N 0.000 description 4
- HMNKTRSOROOSPP-UHFFFAOYSA-N 3-Ethylphenol Chemical compound CCC1=CC=CC(O)=C1 HMNKTRSOROOSPP-UHFFFAOYSA-N 0.000 description 4
- XKFIFYROMAAUDL-UHFFFAOYSA-N 3-amino-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C=C1N XKFIFYROMAAUDL-UHFFFAOYSA-N 0.000 description 4
- WJXSWCUQABXPFS-UHFFFAOYSA-N 3-hydroxyanthranilic acid Chemical compound NC1=C(O)C=CC=C1C(O)=O WJXSWCUQABXPFS-UHFFFAOYSA-N 0.000 description 4
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- 108010016626 Dipeptides Proteins 0.000 description 4
- 108010074860 Factor Xa Proteins 0.000 description 4
- 108010088842 Fibrinolysin Proteins 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 4
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 4
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 4
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 4
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229950011260 betanaphthol Drugs 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 230000002949 hemolytic effect Effects 0.000 description 4
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 4
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 4
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 230000036284 oxygen consumption Effects 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229940049953 phenylacetate Drugs 0.000 description 4
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 4
- 229940012957 plasmin Drugs 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
- 229960004072 thrombin Drugs 0.000 description 4
- 229960005356 urokinase Drugs 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 3
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 3
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 description 3
- XFDUHJPVQKIXHO-UHFFFAOYSA-N 3-aminobenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1 XFDUHJPVQKIXHO-UHFFFAOYSA-N 0.000 description 3
- HHSBHVJQXZLIRW-UHFFFAOYSA-N 3-n,3-n-dimethylbenzene-1,3-diamine Chemical compound CN(C)C1=CC=CC(N)=C1 HHSBHVJQXZLIRW-UHFFFAOYSA-N 0.000 description 3
- ZWUBBMDHSZDNTA-UHFFFAOYSA-N 4-Chloro-meta-phenylenediamine Chemical compound NC1=CC=C(Cl)C(N)=C1 ZWUBBMDHSZDNTA-UHFFFAOYSA-N 0.000 description 3
- GGKZSZZTOMPFNQ-UHFFFAOYSA-N 4-amino-2,6-dibromophenol;hydrochloride Chemical compound Cl.NC1=CC(Br)=C(O)C(Br)=C1 GGKZSZZTOMPFNQ-UHFFFAOYSA-N 0.000 description 3
- WPXNREAXCMFACD-UHFFFAOYSA-N 4-n,4-n-bis(ethylamino)benzene-1,4-diamine Chemical compound CCNN(NCC)C1=CC=C(N)C=C1 WPXNREAXCMFACD-UHFFFAOYSA-N 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 3
- 108090000915 Aminopeptidases Proteins 0.000 description 3
- 102000004400 Aminopeptidases Human genes 0.000 description 3
- 206010007269 Carcinogenicity Diseases 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 108010062466 Enzyme Precursors Proteins 0.000 description 3
- 102000010911 Enzyme Precursors Human genes 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 108010093096 Immobilized Enzymes Proteins 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 102100038297 Kallikrein-1 Human genes 0.000 description 3
- 101710176219 Kallikrein-1 Proteins 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 241000222355 Trametes versicolor Species 0.000 description 3
- 102000014384 Type C Phospholipases Human genes 0.000 description 3
- 108010079194 Type C Phospholipases Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 3
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 150000001718 carbodiimides Chemical class 0.000 description 3
- 230000007670 carcinogenicity Effects 0.000 description 3
- 231100000260 carcinogenicity Toxicity 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 150000002314 glycerols Chemical group 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 238000010647 peptide synthesis reaction Methods 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- CCVYRRGZDBSHFU-UHFFFAOYSA-N (2-hydroxyphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1O CCVYRRGZDBSHFU-UHFFFAOYSA-N 0.000 description 2
- NEZJDVYDSZTRFS-ZIQFBCGOSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-phenoxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=CC=C1 NEZJDVYDSZTRFS-ZIQFBCGOSA-N 0.000 description 2
- MCRMUCXATQAAMN-HNNXBMFYSA-N (2s)-3-(4-hydroxyphenyl)-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=C(O)C=C1 MCRMUCXATQAAMN-HNNXBMFYSA-N 0.000 description 2
- YSRMCZDHEZNRPS-HOTGVXAUSA-N (2s)-5-(diaminomethylideneamino)-2-[[(2s)-1-[2-[(4-methylphenyl)sulfonylamino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 YSRMCZDHEZNRPS-HOTGVXAUSA-N 0.000 description 2
- OZSSOVRIEPAIMP-ZETCQYMHSA-N (2s)-5-[amino(nitramido)methylidene]azaniumyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CCCN=C(N)N[N+]([O-])=O OZSSOVRIEPAIMP-ZETCQYMHSA-N 0.000 description 2
- VJZRBVVLWLEXBB-VROPFNGYSA-N (2s)-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-[2-[(4-methylphenyl)sulfonylamino]acetyl]pyrrolidine-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(C)=CC=C1S(=O)(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC=2C=CC(=CC=2)[N+]([O-])=O)CCC1 VJZRBVVLWLEXBB-VROPFNGYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- NAZDVUBIEPVUKE-UHFFFAOYSA-N 2,5-dimethoxyaniline Chemical compound COC1=CC=C(OC)C(N)=C1 NAZDVUBIEPVUKE-UHFFFAOYSA-N 0.000 description 2
- 125000001257 2,5-xylenyl group Chemical group [H]C1=C([H])C(=C(O*)C([H])=C1C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- AKEUNCKRJATALU-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O AKEUNCKRJATALU-UHFFFAOYSA-N 0.000 description 2
- 125000000577 2,6-xylenyl group Chemical group [H]C1=C([H])C(=C(O*)C(=C1[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- IXQGCWUGDFDQMF-UHFFFAOYSA-N 2-Ethylphenol Chemical compound CCC1=CC=CC=C1O IXQGCWUGDFDQMF-UHFFFAOYSA-N 0.000 description 2
- SMFHPCZZAAMJJO-UHFFFAOYSA-N 2-chloro-5-methylphenol Chemical compound CC1=CC=C(Cl)C(O)=C1 SMFHPCZZAAMJJO-UHFFFAOYSA-N 0.000 description 2
- MNIQECRMTVGZBM-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;7h-purin-6-amine Chemical compound NC1=NC=NC2=C1NC=N2.CN1CCCC1C1=CC=CN=C1 MNIQECRMTVGZBM-UHFFFAOYSA-N 0.000 description 2
- AUUIARVPJHGTSA-UHFFFAOYSA-N 3-(aminomethyl)chromen-2-one Chemical compound C1=CC=C2OC(=O)C(CN)=CC2=C1 AUUIARVPJHGTSA-UHFFFAOYSA-N 0.000 description 2
- WAVOOWVINKGEHS-UHFFFAOYSA-N 3-(diethylamino)phenol Chemical compound CCN(CC)C1=CC=CC(O)=C1 WAVOOWVINKGEHS-UHFFFAOYSA-N 0.000 description 2
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 description 2
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 2
- NHPCFKHZILUMDE-UHFFFAOYSA-N 4-n,4-n-diethylbenzene-1,4-diamine;dihydrochloride Chemical compound Cl.Cl.CCN(CC)C1=CC=C(N)C=C1 NHPCFKHZILUMDE-UHFFFAOYSA-N 0.000 description 2
- DQNAQOYOSRJXFZ-UHFFFAOYSA-N 5-Amino-1-naphthalenesulfonic acid Chemical compound C1=CC=C2C(N)=CC=CC2=C1S(O)(=O)=O DQNAQOYOSRJXFZ-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 208000037487 Endotoxemia Diseases 0.000 description 2
- 206010061968 Gastric neoplasm Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 239000004201 L-cysteine Substances 0.000 description 2
- 235000013878 L-cysteine Nutrition 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241000239205 Merostomata Species 0.000 description 2
- OJGMBLNIHDZDGS-UHFFFAOYSA-N N-Ethylaniline Chemical compound CCNC1=CC=CC=C1 OJGMBLNIHDZDGS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 102000011420 Phospholipase D Human genes 0.000 description 2
- 108090000553 Phospholipase D Proteins 0.000 description 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
- 102000003827 Plasma Kallikrein Human genes 0.000 description 2
- 108090000113 Plasma Kallikrein Proteins 0.000 description 2
- GHBAYRBVXCRIHT-VIFPVBQESA-N S-benzyl-L-cysteine zwitterion Chemical compound OC(=O)[C@@H](N)CSCC1=CC=CC=C1 GHBAYRBVXCRIHT-VIFPVBQESA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 108010018472 chromozym TH Proteins 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 108010032065 cysteine aminopeptidase Proteins 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- QVBQPOJYBWWILD-UHFFFAOYSA-N dimethyl 2-aminobenzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC=CC(C(=O)OC)=C1N QVBQPOJYBWWILD-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 108010084315 endopolyphosphatase Proteins 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 238000005558 fluorometry Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 150000002402 hexoses Chemical class 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 2
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 2
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 2
- 229960004963 mesalazine Drugs 0.000 description 2
- IJFXRHURBJZNAO-UHFFFAOYSA-N meta--hydroxybenzoic acid Natural products OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 150000002772 monosaccharides Chemical group 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 210000001819 pancreatic juice Anatomy 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- BYGOPQKDHGXNCD-UHFFFAOYSA-N tripotassium;iron(3+);hexacyanide Chemical compound [K+].[K+].[K+].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] BYGOPQKDHGXNCD-UHFFFAOYSA-N 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- ATPNWHGYKFXQNF-INIZCTEOSA-N (2r)-3-benzylsulfanyl-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)SCC1=CC=CC=C1 ATPNWHGYKFXQNF-INIZCTEOSA-N 0.000 description 1
- IDSFNACJZVHKIB-KCHLEUMXSA-N (2s)-1-benzoyl-n-[(2s)-1-[[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)NC(=O)[C@H]1N(CCC1)C(=O)C=1C=CC=CC=1)C1=CC=CC=C1 IDSFNACJZVHKIB-KCHLEUMXSA-N 0.000 description 1
- ZNKZJCICBFSACN-GBESFXJTSA-N (2s)-2-[[(2r)-2-amino-3-methylbutanoyl]amino]-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]-4-methylpentanamide Chemical compound CC(C)[C@@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 ZNKZJCICBFSACN-GBESFXJTSA-N 0.000 description 1
- AHYFYYVVAXRMKB-KRWDZBQOSA-N (2s)-3-(1h-indol-3-yl)-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)OCC1=CC=CC=C1 AHYFYYVVAXRMKB-KRWDZBQOSA-N 0.000 description 1
- XHGIWCXAACQYGK-OALUTQOASA-N (2s)-5-(diaminomethylideneazaniumyl)-2-[[(2s)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]pentanoate Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(O)=O)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 XHGIWCXAACQYGK-OALUTQOASA-N 0.000 description 1
- DGYWXYFLXYIOCP-KBPBESRZSA-N (2s)-n-[2-[[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-5-oxopyrrolidine-2-carboxamide Chemical compound N([C@@H](CCCN=C(N)N)C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)C(=O)CNC(=O)[C@@H]1CCC(=O)N1 DGYWXYFLXYIOCP-KBPBESRZSA-N 0.000 description 1
- IAEDWDXMFDKWFU-UHFFFAOYSA-N (4-azaniumylphenyl)-dimethylazanium;dichloride Chemical compound Cl.Cl.CN(C)C1=CC=C(N)C=C1 IAEDWDXMFDKWFU-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YNXICDMQCQPQEW-UHFFFAOYSA-N 1-naphthyl dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CC=CC2=C1 YNXICDMQCQPQEW-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 1
- 125000000098 2,3-xylenyl group Chemical group [H]C1=C([H])C(=C(C(O*)=C1[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001287 2,4-xylenyl group Chemical group [H]C1=C(O*)C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- HOLHYSJJBXSLMV-UHFFFAOYSA-N 2,6-dichlorophenol Chemical compound OC1=C(Cl)C=CC=C1Cl HOLHYSJJBXSLMV-UHFFFAOYSA-N 0.000 description 1
- KEEQZNSCYCPKOJ-UHFFFAOYSA-N 2,6-diethylbenzene-1,4-diamine Chemical compound CCC1=CC(N)=CC(CC)=C1N KEEQZNSCYCPKOJ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- HYNQTSZBTIOFKH-UHFFFAOYSA-N 2-Amino-5-hydroxybenzoic acid Chemical compound NC1=CC=C(O)C=C1C(O)=O HYNQTSZBTIOFKH-UHFFFAOYSA-N 0.000 description 1
- NRXDUMDULDHIEA-VIFPVBQESA-N 2-[[(2s)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]acetic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O NRXDUMDULDHIEA-VIFPVBQESA-N 0.000 description 1
- DNUYOWCKBJFOGS-UHFFFAOYSA-N 2-[[10-(2,2-dicarboxyethyl)anthracen-9-yl]methyl]propanedioic acid Chemical compound C1=CC=C2C(CC(C(=O)O)C(O)=O)=C(C=CC=C3)C3=C(CC(C(O)=O)C(O)=O)C2=C1 DNUYOWCKBJFOGS-UHFFFAOYSA-N 0.000 description 1
- QHXBZNOJMIQGER-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OCCN(CCO)CCO.OC(=O)CC(O)(C(O)=O)CC(O)=O QHXBZNOJMIQGER-UHFFFAOYSA-N 0.000 description 1
- YPNZJHFXFVLXSE-UHFFFAOYSA-N 2-chloro-6-methylphenol Chemical compound CC1=CC=CC(Cl)=C1O YPNZJHFXFVLXSE-UHFFFAOYSA-N 0.000 description 1
- LKGQTURGJNTDLR-UHFFFAOYSA-N 2-chlorobenzene-1,3-diamine Chemical compound NC1=CC=CC(N)=C1Cl LKGQTURGJNTDLR-UHFFFAOYSA-N 0.000 description 1
- HJXIRCMNJLIHQR-UHFFFAOYSA-N 2-n,2-n-dimethylbenzene-1,2-diamine Chemical compound CN(C)C1=CC=CC=C1N HJXIRCMNJLIHQR-UHFFFAOYSA-N 0.000 description 1
- 125000002852 3,5-xylenyl group Chemical group [H]C1=C(O*)C([H])=C(C([H])=C1C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- MRBKRZAPGUCWOS-UHFFFAOYSA-N 3-amino-4-hydroxybenzoic acid Chemical compound NC1=CC(C(O)=O)=CC=C1O MRBKRZAPGUCWOS-UHFFFAOYSA-N 0.000 description 1
- KFSNHOUZAIGMAF-UHFFFAOYSA-N 3-n,3-n-diethylbenzene-1,3-diamine Chemical compound CCN(CC)C1=CC=CC(N)=C1 KFSNHOUZAIGMAF-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- CXNVOWPRHWWCQR-UHFFFAOYSA-N 4-Chloro-ortho-toluidine Chemical compound CC1=CC(Cl)=CC=C1N CXNVOWPRHWWCQR-UHFFFAOYSA-N 0.000 description 1
- ZYZQSCWSPFLAFM-UHFFFAOYSA-N 4-amino-2-chlorophenol Chemical compound NC1=CC=C(O)C(Cl)=C1 ZYZQSCWSPFLAFM-UHFFFAOYSA-N 0.000 description 1
- RUKJCCIJLIMGEP-ONEGZZNKSA-N 4-dimethylaminocinnamaldehyde Chemical compound CN(C)C1=CC=C(\C=C\C=O)C=C1 RUKJCCIJLIMGEP-ONEGZZNKSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- DGRGLKZMKWPMOH-UHFFFAOYSA-N 4-methylbenzene-1,2-diamine Chemical compound CC1=CC=C(N)C(N)=C1 DGRGLKZMKWPMOH-UHFFFAOYSA-N 0.000 description 1
- QAUUDNIGJSLPSX-UHFFFAOYSA-N 4-nitrophenyl acetate Chemical compound CC(=O)OC1=CC=C([N+]([O-])=O)C=C1 QAUUDNIGJSLPSX-UHFFFAOYSA-N 0.000 description 1
- WBSMIPLNPSCJFS-UHFFFAOYSA-N 5-chloro-2-methoxyaniline Chemical compound COC1=CC=C(Cl)C=C1N WBSMIPLNPSCJFS-UHFFFAOYSA-N 0.000 description 1
- KKFPXGXMSBBNJI-UHFFFAOYSA-N 5-chloro-2-methylphenol Chemical compound CC1=CC=C(Cl)C=C1O KKFPXGXMSBBNJI-UHFFFAOYSA-N 0.000 description 1
- LGDFHDKSYGVKDC-UHFFFAOYSA-N 8-hydroxyquinoline-5-sulfonic acid Chemical compound C1=CN=C2C(O)=CC=C(S(O)(=O)=O)C2=C1 LGDFHDKSYGVKDC-UHFFFAOYSA-N 0.000 description 1
- 108010055851 Acetylglucosaminidase Proteins 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102100025683 Alkaline phosphatase, tissue-nonspecific isozyme Human genes 0.000 description 1
- 102100031317 Alpha-N-acetylgalactosaminidase Human genes 0.000 description 1
- 102100034561 Alpha-N-acetylglucosaminidase Human genes 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- 102100032126 Aminopeptidase B Human genes 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 244000186140 Asperula odorata Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 102100034560 Cytosol aminopeptidase Human genes 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 101000874334 Dalbergia nigrescens Isoflavonoid 7-O-beta-apiosyl-glucoside beta-glycosidase Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 102000004860 Dipeptidases Human genes 0.000 description 1
- 108090001081 Dipeptidases Proteins 0.000 description 1
- 101000757733 Enterococcus faecalis (strain ATCC 700802 / V583) Autolysin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 235000008526 Galium odoratum Nutrition 0.000 description 1
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 102000002397 Kinins Human genes 0.000 description 1
- 108010093008 Kinins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
- 150000008575 L-amino acids Chemical group 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical group C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 1
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 101000757734 Mycolicibacterium phlei 38 kDa autolysin Proteins 0.000 description 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical group CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- NEZJDVYDSZTRFS-RMPHRYRLSA-N Phenyl beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1 NEZJDVYDSZTRFS-RMPHRYRLSA-N 0.000 description 1
- 108010003781 Phosphoamidase Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 101150108015 STR6 gene Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000239222 Tachypleus Species 0.000 description 1
- 241000239224 Tachypleus tridentatus Species 0.000 description 1
- 108010070926 Tripeptide aminopeptidase Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108010083404 Val-Leu-Arg-p-nitroanilide Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 108010012864 alpha-Mannosidase Proteins 0.000 description 1
- 102000019199 alpha-Mannosidase Human genes 0.000 description 1
- 108010015684 alpha-N-Acetylgalactosaminidase Proteins 0.000 description 1
- 108010009380 alpha-N-acetyl-D-glucosaminidase Proteins 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 108090000449 aminopeptidase B Proteins 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 108010008753 beta-N-Acetyl-Galactosaminidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 108010038658 exo-1,4-beta-D-xylosidase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- KZNQNBZMBZJQJO-YFKPBYRVSA-N glyclproline Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 150000008273 hexosamines Chemical group 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000004698 iron complex Chemical class 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical class C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012454 limulus amebocyte lysate test Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- JDEJGVSZUIJWBM-UHFFFAOYSA-N n,n,2-trimethylaniline Chemical compound CN(C)C1=CC=CC=C1C JDEJGVSZUIJWBM-UHFFFAOYSA-N 0.000 description 1
- CWOMTHDOJCARBY-UHFFFAOYSA-N n,n,3-trimethylaniline Chemical compound CN(C)C1=CC=CC(C)=C1 CWOMTHDOJCARBY-UHFFFAOYSA-N 0.000 description 1
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical compound CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 description 1
- YQYUUNRAPYPAPC-UHFFFAOYSA-N n,n-diethyl-2-methylaniline Chemical compound CCN(CC)C1=CC=CC=C1C YQYUUNRAPYPAPC-UHFFFAOYSA-N 0.000 description 1
- CIPVVROJHKLHJI-UHFFFAOYSA-N n,n-diethyl-3-methylaniline Chemical compound CCN(CC)C1=CC=CC(C)=C1 CIPVVROJHKLHJI-UHFFFAOYSA-N 0.000 description 1
- HKJNHYJTVPWVGV-UHFFFAOYSA-N n,n-diethyl-4-methylaniline Chemical compound CCN(CC)C1=CC=C(C)C=C1 HKJNHYJTVPWVGV-UHFFFAOYSA-N 0.000 description 1
- BXBPNSQUZBBTQT-UHFFFAOYSA-N n,n-dimethylacetamide;methylsulfinylmethane Chemical compound CS(C)=O.CN(C)C(C)=O BXBPNSQUZBBTQT-UHFFFAOYSA-N 0.000 description 1
- VENDXQNWODZJGB-UHFFFAOYSA-N n-(4-amino-5-methoxy-2-methylphenyl)benzamide Chemical compound C1=C(N)C(OC)=CC(NC(=O)C=2C=CC=CC=2)=C1C VENDXQNWODZJGB-UHFFFAOYSA-N 0.000 description 1
- QQVNCBCBFNWLJX-KCHLEUMXSA-N n-[(2s)-1-[[(2s)-1-[[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]benzamide Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)NC(=O)C=1C=CC=CC=1)C1=CC=CC=C1 QQVNCBCBFNWLJX-KCHLEUMXSA-N 0.000 description 1
- GYEHHVCMWRKKMY-UNMCSNQZSA-N n-[(2s)-1-[[2-[[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]benzamide Chemical compound N([C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)C(=O)C1=CC=CC=C1 GYEHHVCMWRKKMY-UNMCSNQZSA-N 0.000 description 1
- IAKVKXNIMLQHPA-UHFFFAOYSA-N naphthalen-1-yl hexadecanoate Chemical compound C1=CC=C2C(OC(=O)CCCCCCCCCCCCCCC)=CC=CC2=C1 IAKVKXNIMLQHPA-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- LVZSQWIWCANHPF-UHFFFAOYSA-N p-nitrophenyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 LVZSQWIWCANHPF-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 108010017378 prolyl aminopeptidase Proteins 0.000 description 1
- 108010003854 prolyl-phenylalanyl-arginine-4-nitroanilide Proteins 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
- C12Q2337/10—Anilides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/976—Trypsin; Chymotrypsin
Definitions
- This invention relates to a method of assaying a compound of the formula ##STR2## wherein R 1 is hydroxyl or amino, or hydrogen if at least one of R 2 , R 3 , R 4 , R 5 or R 6 is hydroxyl or amino, and R 2 , R 3 , R 4 , R 5 and R 6 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R 5 and R 6 together form a ring, which comprises reacting the compound with an oxidase which consumes oxygen and generates a pigment, and measuring at least one of the detectable changes in the reaction system.
- the present invention also provides an assay of hydrolase, in which compound [I] is liberated by the action of the hydrolase to be assayed, from a synthetic substrate, which has a component of the structure of compound [I], then oxidizing the thus-produced compound [I] by an oxidase in the presence of a coupler, and measuring the detectable changes.
- Enzymatic analysis of a compound in a sample using an enzyme to form a pigment is well known. Most of these methods are assay methods using peroxidase, wherein hydrogen peroxide or phenol, or a compound which generates or liberates the same, is measured.
- peroxidase acts in the presence of phenol and a chromogen such as 4-aminoantipyrine, to promote the reaction: H 2 O 2 ⁇ H 2 O+[O], in which the phenol and chromogen are oxidatively condensed by the oxidative action of [O] to form a pigment.
- the amount of hydrogen peroxide can be measured by measuring the absorption at the specific absorption wavelength of the pigment.
- ⁇ -D-glucose forms hydrogen peroxide by the action of glucose oxidase as follows:
- the generated hydrogen peroxide is measured and the amount of ⁇ -D-glucose can thus be assayed.
- This method is the preferred assay method for a reaction system which contains hydrogen peroxide or liberates or generates hydrogen peroxide, and is used in clinical biochemistry.
- hydrogen peroxide should not be used as a reagent. Since hydrogen peroxide is an unstable compound, assaying a phenol-series compound by this method is not preferred, and in fact is almost unusable.
- the enzymatic reaction for forming a pigment other than peroxidase is that nicotine adenine dinucleotide or nicotine adenine dinucleotide phosphate [NAD(P)] is reduced to NAD(P)H by a dehydrogenase system, and the generated NAD(P) is linked with diaphorase and an electron transfer pigment to form formazane which is then measured by colorimetry.
- NAD(P) nicotine adenine dinucleotide or nicotine adenine dinucleotide phosphate
- This previous assay method has a number of advantages, such as providing a mild enzymatic assay as compared with chemical methods, and the possibility of automatic rate assay.
- this earlier assay method when a phenol derivative is oxidized by oxidase, the phenol derivative is changed to a compound having an absorption maximum at 350-500 nm.
- the compound [I] such as 3,5-dibromo-4-hydroxyaniline does not show color upon reaction with oxidase when a coupler is not used; however, it forms a pigment having an absorption maximum at 600-700 nm by oxidative condensation in the presence of a coupler. This reaction can therefore be considered to proceed by a previously unknown and novel reaction schema.
- An object of the present invention is to provide an assay method of a compound [I] which comprises measuring the detectable changes in a reaction system by treating the compound to be assayed with an oxidase which consumes oxygen and generates a pigment in the presence of a coupler.
- Another object of the present invention is to provide an assay method of hydrolase which comprises liberating a compound [I] from a synthetic substrate having a component of compound [I] in its structure by the action of hydrolase, treating the thus-produced component with an oxidase which consumes oxygen and generates a pigment in the presence of a coupler, and measuring the detectable changes in the reaction system.
- the oxidases are those which consume oxygen and generate a pigment.
- examples of the oxidase are ascorbate oxidase, laccase, aminophenol oxidase, polyphenol oxidase and tyrosinase.
- Preferred examples are ascorbate oxidase obtained from pumpkin, cucumber or chayote (Sechium edule), laccase obtained from a japan (urushi, japanese lacquer), Bacidiomycetes (Coriolus versicolor, Rhizopus or Polyporus versicolor), and tyrosinase. [J. Biochem., 50, 264 (1961), Biochim. Biophys. Acta, 73, 204 (1963), Acta Chem.
- enzymes can also be used. These enzymes can be used in the form of immobilized enzymes.
- the immobilized enzyme can be contacted with an oxygen electrode in an automatic analyzer and the electrochemical changes can be measured. Expensive enzyme can be saved by the use of these electrodes.
- the sensor having an enzyme electrode of an immobilized enzyme and an oxygen electrode, can provide an assay method which is rapid, uses less reagent, and can be used for repeated measurements. Also colored specimens can be measured.
- the couplers are substances which can oxidatively condense with a compound [I] to form a pigment.
- the preferred coupler is a compound of the formula ##STR3## wherein R 7 is hydroxyl, amino or substituted amino R 8 , R 9 , R 10 , R 11 and R 12 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R 11 and R 12 together form a ring.
- coupler for amino compound [I] examples include phenol, salicylic acid, m-hydroxybenzoic acid, 2,6-dihydroxybenzoic acid, 2-amino-3-hydroxybenzoic acid, 2-hydroxy-5-aminobenzoic acid, p-hydroxybenzoic acid, methyl salicylate, o-methylphenol, m-methylphenol, p-methylphenol, o-methylphenol, m-methoxyphenol, p-methoxyphenol, o-chlorophenol, m-chlorophenol, p-chlorophenol, 2,3-dimethylphenol, 2,4-dimethylphenol, 2,5-dimethylphenol, 2,6-dimethylphenol, 3,5-dimethylphenol, 2,6-dichlorophenol, o-aminophenol, m-aminophenol, p-bromophenol, o-ethylphenol, m-ethylphenol, 2,4-dichlorophenol, 2,4-dibromophenol, 2,6-
- the preferred coupler is a compound of the formula ##STR4## wherein R 13 is amino or substituted amino, and R 14 , R 15 , R 16 , R 17 and R 18 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R 17 and R 18 together form a ring.
- couplers for phenol compound [I] are N-ethylaniline, N,N-dimethylaniline, N,N-diethylaniline, N,N-dimethyl-o-toluidine, N,N-dimethyl-p-toluidine, N,N-diethyl-o-toluidine, N,N-diethyl-m-toluidine, N,N-diethyl-p-toluidine, anthranylic acid, p-dimethylaminobenzoic acid, p-chloro-o-toluidine, m-phenylenediamine, p-phenylenediamine, aniline, o-methylaniline, m-methylaniline, o-carboxyaniline, o-chloroaniline, m-chloroaniline, m-bromoaniline, 2-methyl-5-carboxyaniline, N,N-ethyl-hydroxyethylaniline
- amino compound [I] examples include 4-hydroxy-3,5-dichloroaniline, 4-hydroxy-3,5-dibromoaniline, p-N,N-diethylaminoaniline, p-N,N-dimethylaminoaniline, m-phenylenediamine, p-phenylenediamine, o-aminophenol, m-aminophenol, aniline, o-toluidine, m-toluidine, o-carboxyaniline, o-chloroaniline, m-chloroaniline, m-bromoaniline, m-N,N-dimethylaminoaniline, 2-chloro-5-aminoaniline, 2-methyl-3-chloroaniline, 2,5-dimethoxyaniline, 2-methyl-3-aminoaniline, 2-methyl-5-aminoaniline, 2-methyl-5-carboxyaniline, 2-hydroxy-6-carboxyaniline, 2-hydroxy-5-methylaniline, 3-
- phenol compound [I] examples include 4-amino-2,6-dichlorophenol, 4-amino-2,6-dibromophenol, o-aminophenol, m-aminophenol, p-aminophenol, m-carboxyphenol, p-carboxyphenol, phenol, o-chlorophenol, m-chlorophenol, p-chlorophenol, p-bromophenol, o-ethylphenol, m-ethylphenol, o-methylphenol, m-methylphenol, p-methylphenol, o-methoxyphenol, salicyclic acid, methylsalicylate, o-carboxymethylphenol, m-N,N-diethylaminophenol, 2,4-dichlorophenol, 2,4-dibromophenol, 2,6-dibromophenol, 2,6-dimethoxyphenol, 3,5-dimethylphenol, 2,5-dimethylphenol, 2,4-dimethylphenol,
- amino compound [I] or phenol compound [I] having both amino and hydroxyl are o-, m- or p-aminophenol, 2-chloro-4-aminophenol, 2-amino-4-carboxyphenol, 2-amino-4-methylphenol, 2-carboxy-4-aminophenol, 2-amino-4-chlorophenol, 2,6-dichloro-4-aminophenol and 2,6-dibromo-4-aminophenol.
- any couplers for amino compound [I] or phenol compound [I] can be used as the aminophenol series compounds hereinabove; however, when the coupler and the aminophenol compound are identical, these combinations of the coupler and the aminophenol compound should be excluded.
- a sample containing compound [I] is treated with oxidase which consumes oxygen and generates a pigment in the presence of a coupler [IV].
- the amount of coupler used is equimolar or an excess for compound [I], and is an amount having a non-inhibitory action toward the enzyme.
- These couplers should be prepared for use in constant concentration in a buffer solution of neutral pH, such as Tris-HCl, phosphate, dimethylglutarate-NaOH, acetate, imidazole-HCl, Pipes-NaOH or citrate buffer.
- the amount of enzyme used is generally (for 0.1-5 ml of 0.1 mM/lit.
- reaction temperature is about 25°-40° C., preferably about 37° C.
- reaction time varies depending on the amount of enzyme used, the temperature and the assay procedure, and is generally more than one minute. Rate assay can preferably be performed in one minute and the other colorimetric assay is preferably performed in 5 minutes.
- At least one of the detectable changes is measured, and this is performed by measuring the amount of consumed oxygen or the generated pigment.
- Oxygen can be measured by electrochemical means such as an oxygen electrode.
- the amount of oxygen can be measured by colorimetry at 500-750 nm maximum absorption wavelength.
- the amount of compound [I] in the sample can be measured by calculation from a standard curve.
- a synthetic substrate having a component of that compound [I] in its structure can also be assayed.
- the synthetic substrate should be a substrate for hydrolase such as peptidase, protease, amylase, glycosidase, phosphatase, esterase or lipase.
- hydrolases are commercially available enzymes, cultured broths containing enzymes, and specimens such as cells, tissues, urine, saliva and serum.
- a sample containing the hydrolase is mixed with a corresponding synthetic substrate, and the mixture is incubated at 37° C. to liberate the compound [I].
- This compound [I] is treated with an oxidase which consumes oxygen and generates a pigment in the presence of a coupler as hereinbefore, to permit assay of the activity of the enzyme in the sample.
- Embodiments of enzyme to be assayed, synthetic substrates and their production are illustrated as follows:
- aminopeptidase has been known generically as an enzyme which acts on peptide chains to split the amino terminal and liberate amino acids or peptides.
- aminopeptidase are cysteine-aminopeptidase (EC: 3. 4. 11. 3), proline aminopeptidase (EC: 3. 4. 11. 5), arginine aminopeptidase (EC: 3. 4. 11. 6), tripeptide aminopeptidase (EC: 3. 4. 11. 4), X-prolyl dipeptidylaminopeptidase (wherein X is an acidic, neutral or basic amino acid residue), and dipeptidase (EC: 3. 4. 13. 11).
- Cysteine aminopeptidase (hereinafter called CAP) is found in increased quantity in the blood during an abnormal pregnancy, and an assay of CAP is useful for diagnosis of the placental function and is used for checking a clinical diagnosis during the period of pregnancy.
- Synthetic substrate S-benzyl-L-cysteinyl-p-nitroanilide or S-benzyl-L-cysteinyl-N,N-dimethylaminoanilide has been used for that assay.
- CAP activity is assayed by measuring the yellow color of the p-nitroaniline liberated from substrate S-benzyl-L-cysteinyl-p-nitroanilide. Measuring the yellow color thereof is effected by bilirubin serum or hemolytic serum.
- liberated p-nitroaniline is chemically reacted with p-dimethylamino cinnamaldehyde to form a red pigment which is measured at 565 nm.
- a synthetic substrate which is a compound having a component of amino compound [I] in its structure, obtained by reacting its amino group with the carboxyl group of an amino acid or peptide.
- This synthetic substrate has the formula ##STR5## wherein one of R' 1 and R' 2 is R 19 CO--NH-- and the other is hydrogen, R 19 CO-- is an amino acid residue or peptide residue, and R 3 , R 4 , R 5 and R 6 have the same meanings as hereinbefore.
- R 19 CO-- group examples include S-benzyl-L-cystenyl, L-alanyl and X-prolyl, wherein X is an acidic, neutral or basic amino acid residue.
- a sample containing peptidase is reacted with a synthetic substrate of the formula [V] to liberate an amino compound [I] which is subjected to oxidative condensation with a corresponding coupler by oxidase.
- the resultant mixture is colorimetrically measured at 500-750 nm.
- the method hereinabove is the preferred method for automatic rate assay.
- a synthetic substrate [V] can be produced by conventional peptide synthesis, for example by the condensation of S-benzyl-L-cysteine and an amino compound [I].
- S-benzyl-L-cystein can be obtained by the benzylation of the thiol group in L-cysteine. In this synthesis, the functional group is protected if necessary. Protection is performed by any conventional method of peptide synthesis.
- the ⁇ -amino group in L-cysteine is protected by a conventional protective group such as t-butoxycarbonyl, t-amyloxycarbonyl, benzyloxycarbonyl, adamantanyloxycarbonyl or o-nitrophenyl-thionitro-substituted benzyloxycarbonyl.
- a conventional protective group such as t-butoxycarbonyl, t-amyloxycarbonyl, benzyloxycarbonyl, adamantanyloxycarbonyl or o-nitrophenyl-thionitro-substituted benzyloxycarbonyl.
- the ⁇ -carboxyl group of S-benzyl-L-cysteine, wherein the ⁇ -amino group is protected is activated for example by converting to an acid azide, acid anhydride, acid halogenide, acid imidazolide or activated ester, or by treating with carbodiimide, N,N-carbonyldiimidazole or an isoxazolium salt such as Woodward reagent.
- the activated compound is reacted with an amino compound [I], preferably by the carbodiimide, azide, acid halogenide, activated ester or acid anhydride method.
- the reaction is carried out in an inert solvent such as dimethylformamide, dimethylacetamide dimethylsulfoxide, tetrahydrofuran, benzene, xylene, toluene or diethyl ether at -30° C. to room temperature, generally for 30 minutes to 50 hours, at an equimolar ratio of both compounds.
- the protective group for the ⁇ -amino group is removed.
- t-butoxycarbonyl is removed by 2N-hydrogen chloride in acetic acid or trifluoroacetic acid
- benzyloxycarbonyl is removed by catalytic hydrogenation using palladium-carbon or hydrogen bromide in acetic acid.
- the amino compound is a liquid, it can be used as the reactive liquid medium, or benzene can be used.
- the reaction proceeds at 50°-100° C. for 20 minutes to 5 hours.
- the thus-obtained synthetic substrate can be purified by conventional extraction, washing, chromatography or otherwise.
- the product can also be prepared as its salt by reacting with an inorganic acid such as hydrochloric, hydrobromic or phosphoric, or an organic acid such as formic, acetic, propionic, or oxalic.
- the enzymatic activity in a specimen such as serum can be assayed by adding a synthetic substrate in a buffer solution, and reacting the liberated amino compound [I] with a coupler in the presence of an oxidase.
- X-PDAP X-prolyl-dipeptidyl-aminopeptidase
- GPDAP glycylprolyl-dipeptidyl aminopeptidase
- Serum X-PDAP activity increases in acute or chronic hepatitis, hepatocirrhosis or tumor of the bile duct, and decreases in gastric tumor such as stomach cancer or pancreatic tumor. Assaying X-PDAP is useful for the diagnosis of gastric tumor.
- X is glycine, for example (1) Gly-L-Pro- ⁇ -naphthylamide, (2) Gly-L-Pro-p-nitroanilide, (3) Gly-L-Pro-p-phenylazoanilide or (4) 7-(Gly-L-Pro)-4-methylcoumarinamide.
- an assay method using (1) is a method in which enzymatically-liberated ⁇ -naphthylamine is chemically colored by 3-methyl-2-benzothiazolynone hydrazone (MBTH)-FeCl 3 and colorimetrically measured.
- ⁇ -naphthylamine has carcinogenicity and so is not hygienically safe.
- the method using (2) is a colorimetric method of measuring liberated yellow-colored p-nitroaniline, and is adversely affected by bilirubin serum or hemolytic serum. Methods using (3) and (4) also have disadvantages.
- the present synthetic substrate is a compound wherein the amino group in amino compound [I] is combined with an X-L-prolyl group.
- group X are amino acid residues, for example neutral amino acids such as glycine or alanine, acidic amino acids such as aspartic acid or glutamic acid, or basic amino acids such as lysine or arginine. Any type of L-, D- or Dl-amino acid can also be used.
- a synthetic substrate dipeptide derivative can be used as the free base or as its salt such as p-toluenesulfonate, hydrochloride or hydrobromide.
- Preferred dipeptide derivatives are compounds wherein X is a neutral or basic amino acid; and dipeptides wherein X is an acidic amino acid are less hydrolyzed.
- the present synthetic substrate can be synthesized by any conventional peptide synthesis.
- the protective group of N-protected-X-prolyl-amino compound [I] is removed.
- N-protected amino acid-L-prolyl-amino compound [I] is synthesized by reacting an L-prolyl-amino compound [I] with an N-protected amino acid using a condensing reagent such as carbodiimide, or by the activated ester method using an N-protected amino acid having an activated carboxyl group.
- the protective group can be selected from conventional preferred protective groups, for example benzyloxycarbonyl, t-butyloxycarbonyl, t-amyloxycarbonyl or formyl.
- the functional side group if any, is previously protected by any conventional method.
- the side chain carboxy group in acidic amino acid is protected by a benzyl ester.
- the guanidino group in arginine is protected by any conventional protective group such as tosyl, nitro, p-nitrobenzyloxycarbonyl or 2-(isopropyloxycarbonyl)-3,4,5,6-tetrachlorobenzoyl, preferably tosyl or nitro.
- the N- ⁇ -amino group in lysine is preferably protected by any conventional protective group for an ⁇ -amino group.
- the protective group of an N-protected-X-L-prolyl-amino compound [I] is removed by any conventional method.
- Dipeptide derivatives can also be obtained by a method wherein previously-synthesized N-protected-X-L-proline is condensed with an amino compound [I] to obtain an N-protected-X-L-prolyl-amino compound [I]; then the protective group is removed.
- Protease is a general term for enzymes which hydrolyze peptide bonds of peptides and proteins. Examples are pepsin, trypsin, ⁇ -chymotrypsin, microbial protease, thrombin, plasmin, plasma kallibrein tissue kallikrein, urokinase, factor Xa, collagenase, elastase or cathepsin.
- the diagnostically important proteinases are trypsin and ⁇ -chymotrypsin for pancreatic function and protease for the clotting system or fibrinolytic system such as plasmin, thrombin, plasma kallitrein, tissue kallikrein, urokinase or factor Xa.
- chromogenic peptide derivatives have been used as synthetic substrates for these assays.
- substrates can be mentioned:
- liberated p-nitroaniline, aminomethylcoumarin or aminoisophthalate dimethyl ester can be measured by the action of an enzyme in the specimen.
- liberated p-nitroaniline shows a yellow color and is disadvantageously affected by, for example, jaundice color or hemolytic red color.
- Aminomethylcoumarin or aminoisophthalate dimethyl ester is measured by fluorometry and hence is disadvantageously affected by serum component.
- a deproteinization procedure is required.
- the substrates for trypsin and chymotrypsin are generally acyl-basic amino acid- or acyl-aromatic amino acid-p-nitroanilide.
- p-Nitroaniline liberated therefrom is measured for assaying these enzymes. Similar disadvantages are found.
- a compound of formula [V] hereinbefore for example an acyl-basic amino acid (peptide having C terminal basic amino acid)-amino compound [I] or an acyl-aromatic amino acid-amino compound, is used as the synthetic substrate, and an amino compound [I] is liberated from this synthetic substrate by the action of trypsin, chymotrypsin or protease (an enzyme acting on the blood clotting system and fibrinolytic system) in the specimen.
- the liberated amino compound [I] is oxidatively condensed in the presence of a coupler by an oxidase, and the pigment formed is colorimetrically measured.
- the method is advantageously automated for rate-assay and is not affected by serum components because it has a specific absorption maximum wavelength at 500-750 nm.
- acyl-basic amino acids in synthetic substrates for these enzymes are as follows:
- Synthetic substrates having these components can also be produced in the same way as illustrated in connection with CAP and GPDAP hereinbefore.
- An example of synthesis of an amino compound [I] having N,N-diethylamino-p-phenylenediamine is as follows:
- Boc-Arg(NO 2 )-OH and N,N-diethylamino-p-phenylenediamine (DEAA) are condensed by a water soluble carbodiimide (WSC) to obtain Boc-Arg(NO 2 )-DEAA.
- WSC water soluble carbodiimide
- Boc- tert-butyloxycarbonyl group
- H-Arg(NO 2 )-DEAA and the amino-group-protected peptides are condensed in the same way as for CAP or GPDAP, for example by dehydration condensation in the presence of WSC in butanol, and the NO 2 group is removed by catalytic reduction with palladium/carbon to obtain an acylated basic amino acid-amino compound [I].
- the compound [V] can be used for the detection of bacterial endotoxin.
- trace analysis of bacterial endotoxin using the phenomenon of gelation by amoebocyte lysate of horseshoe crabs and a trace amount of bacterial endotoxin has been performed.
- endotoxin has been used in clinical pathology.
- a lymrus amoebocyte lysate test in the surgical field is used for clinical diagnosis of disease findings of exogenous endotoxemia or endotoxin shock caused by diseases showing an apparent infectious nidus.
- the effect of intestinal Gram negative bacterial endotoxin on hepatopathy and endogenous endotoxemia for example the decrease of recticuloendotherial system functions such as detoxication of bacterial endotoxin in the liver, are a problem.
- the clinical determination of endotoxin on blood clotting, the fibrinolystic system, the kinin system, the circulatory system and the immune system has become important.
- specimens such as the patient's body fluids, especially blood, ascites, urine, pancreatic juice, liquor cerebrospinalis or bile, are used.
- body fluids especially blood, ascites, urine, pancreatic juice, liquor cerebrospinalis or bile.
- body fluids have their own color, and these colors and the pigments caused by diseases such as the jaundice deep yellow color and the hemolytic red color, inhibit colorimetry.
- body fluids contain fluorescent substances and hence fluorometry may be inhibited.
- a synthetic substrate of compound [V] wherein R 19 CO-- is R' 19 -Gly-Arg, in which R' 19 is an L-amino acid residue or a peptide residue having a protected N-terminal, and amoebocyte lysate and/or an enzyme precursor isolated therefrom, are reacted with a specimen containing bacterial endotoxin to liberate an amino compound [I].
- the amino compound [I] is oxidatively condensed with a coupler by oxidase to colorimetrically assay the endotoxin.
- the said colorimetric assay can be carried out at 500-750 nm and is preferred for rate assay in an automatic analysis without being inhibited by contaminants in the specimen serum.
- Amoebocyte lysate can be obtained by the hypotonic treatment of amoebocytes in the lymphocytes of horseshoe crabs, or as a commercial product (LAL-test; lymus amoebocyte lysate test).
- LAL-test lymus amoebocyte lysate test.
- Commercially available products are, for example Pregel (Difco Lab., U.S.A.) and Pyrogent (Mallinckrodt Inc., U.S.A.)
- the isolation and purification of the enzyme precursor can be effected by treating an amoebocyte lysate by column chromatography, electrophoresis, electrofocusing or affinity chromatography.
- amoebocyte lysate or the enzyme precursor separated therefrom is activated by bacterial endotoxin to form an active enzyme which acts specifically on a peptide of synthetic substrate [V], wherein R' 19 is, for example Boc-Leu-, Boc-Val-Leu-, Boc-Ser-, Boc-Val-Ser-, Bz-Leu-, Bz-Val-Leu-, Bz-Ser- or Bz-Val-Ser-.
- R' 19 is, for example Boc-Leu-, Boc-Val-Leu-, Boc-Ser-, Boc-Val-Ser-, Bz-Leu-, Bz-Val-Leu-, Bz-Ser- or Bz-Val-Ser-.
- sugar hydrolase examples include amylase, dextranase (EC: 3.2.1.11), cellulase (EC: 3.2.1.4) and glycosidase.
- Amylase can be classified as ⁇ -amylase (EC: 3.2.1.1), ⁇ -amylase (EC: 3.2.1.2) or ⁇ -amylase (EC: 3.2.1.3).
- ⁇ -amylase splits the ⁇ [1 ⁇ 4]-linkage between the glucose moiety in starch or lower a polymerized glucose and the oligomer.
- the said enzyme is originally produced in the pancreas and salivary gland, and increases due to acute pancreatitis. Assaying ⁇ -amylase is therefore an important clinical diagnostic procedure.
- the blue starch method is a widely used method in which the blue color liberated by amylase action is colorimetrically assayed.
- the substrate is insoluble in water and filtration is essential for colorimetry but is undesirable for an automatic procedure.
- an assay method using a synthetic substrate for amylase is known. This latter method comprises reacting a synthetic substrate p-nitrophenylmaltopentaoside with ⁇ -amylase, liberating p-nitrophenyl by action of ⁇ -glucosidase and measuring the same by colorimetry. But this method is disadvantageous for assaying serum amylase because the reaction mixture is yellow, like bilirubin serum or hemolyzate.
- the present invention is an improved assay method which is also advantageous for automatic rate assay.
- a synthetic substrate which is prepared by condensing a hydroxyl group of a malto-oligosaccharide and a phenolic hydroxyl group of a phenol compound [I].
- the synthetic substrate is hydrolyzed by amylase at the malto-oligosaccharide moiety to liberate the phenol compound [I] in combination with glucoside, maltoside or maltopentaoside, which is treated with ⁇ - and ⁇ -glucosidase to form the phenol compound [I].
- the liberated phenol compound [I] is measured colorimetrically.
- Malto-oligosaccharides used in the present invention include saccharides consisting of 2-10 D-glucose with an ⁇ -1,4-glucoside bond. Examples are maltose, maltotriose, maltotetraose, maltopentaose and maltohexaose. Maltotetraose, maltopentaose and maltohexaose of the formula [VI] hereinbelow are preferred.
- phenol compound [I] examples are compounds having ⁇ - or ⁇ -linkage with malto-oligosaccharide or its reduced terminal, which are easily hydrolyzed by ⁇ -glucosidase or ⁇ -glucosidase and are easily measurable.
- the said phenol compound [I] includes aminophenol series compounds as set forth hereinbefore.
- the synthetic substrate of the present invention is a compound of the formula ##STR6## wherein one of R" 1 and R" 2 is (S)n-O- and the other is hydrogen, S is a monosaccharide unit, n is an integer greater than one, and R 3 , R 4 , R 5 and R 6 having the same meanings as hereinbefore.
- a compound wherein (S) is a glucose moiety and n 2-8 to preferred.
- the synthetic substrate [VI] is prepared by the conventional synthetic method with a malto-oligosaccharide.
- a malto-oligosaccharide is acetylated, and acetyl maltooligosaccharide is condensed with phenol compound [I], then the resulting compound is deacetylated to prepare the product.
- phenol compound [I] phenol compound [I]
- Serum amylase is assayed by incubating the enzyme and a synthetic substrate, and ⁇ -glucosidase, if required with ⁇ -glucosidase, in a buffer solution, and measuring the thus-liberated phenol compound [I] with a coupler and an oxidase.
- glucosidase to be assayed examples include ⁇ -glucosidase (EC: 3.2.1.20), ⁇ -glucosidase (EC: 3.2.1.21), ⁇ -galactosidase (EC: 3.2.1.22), ⁇ -galactosidase (EC: 3.2.1.23), ⁇ -mannosidase (EC: 3.2.1.24), ⁇ -mannosidase (EC: 3.2.1.25), ⁇ -glucuronidase (EC: 3.2.1.31), ⁇ -xylosidase (EC: 3.2.1.37), ⁇ -L-fusocidase (EC: 3.2.1.51), ⁇ -N-acetylgalactosaminidase (EC: 3.2.1.49), ⁇ -N-acetylglucosaminidase (EC: 3.2.1.50), ⁇ -N-acetylgalactosaminidase (EC: 3.2.1.53), and ⁇ -N-acetylgluco
- a pentose unit such as a xylose unit, a hexose unit such as glucose unit, a galactose unit, a mannose unit or a fucose unit, a hexosamine unit such as an N-acetylgalactosamine unit or an N-acetylglucosamine unit and a uronic acid unit such as glucuronic acid can be mentioned.
- Glucosidase can be assayed by liberating a phenol compound [I] from a synthetic substrate by the action of the corresponding glucosidase, and measuring the phenol compound [I] with a coupler and an oxidase.
- a commercially available substrate for glucosidase phenyl- ⁇ -D-glucoside
- a sample containing glucosidase in a suitable buffer at 37° C. is contacted with a sample containing glucosidase in a suitable buffer at 37° C., and liberated phenol is converted to a coloring substance with the corresponding coupler and oxidase.
- Phosphatase is an enzyme which catalyzes the hydrolysis of phosphate esters, and undergoes not only hydrolysis but also a reversible reaction, the direction of the reaction depending on the relative concentration of substrate and product.
- phosphate ester compounds In the human body, many phosphate ester compounds are known. The phosphatases which participate in the metabolism of these phosphate esters are classified according to the bond site of the substrate, i.e:
- phosphomonoesterase hydrolyzes nonspecifically phenylphosphate, p-nitrophenylphosphate or ⁇ -glycerosphosphate.
- alkaline phosphatase EC: 3.1.3.1
- ACP acid phosphatase
- AlP originates from the bones, liver, placenta, small intestine or mucosa; and since it is mainly located in the cell membranes, the enzyme participates in active transport through membranes, namely, metabolism.
- Serum ACP assay is mainly used for the diagnosis of prostatic cancer, and is said to show some effect on the metastasis of mammary cancers.
- phosphatase has been assayed by a method of measuring liberated phosphate after hydrolysis of an organic phosphate ester, and a method of measuring liberated phenol from a substrate which is an organic phosphate ester of a phenol.
- a method measuring phenols is that a substrate comprising phenyl phosphate is hydrolyzed to liberate phenol, and the liberated phenol is oxidatively condensed with 4-aminoantipyrine in the presence of potassium ferricyanate to form red-colored quinone which is colorimetrically measured.
- a modified Kind-King method is that a borate buffer is used for stabilizing the coloring.
- the method using an alkaline salt of an aromatic sulfonehalogenamide such as Chloramine T etc. in place of potassium ferricyanide (Jap. Pat. Unexam. Publ. No. 52-155597) or using hydrogen peroxideperoxidase has also been proposed.
- potassium ferricyanate is a cyanide compound which causes polution, and they are not advantageous for rate assay; and moreover, the hydrogen peroxide is unstable.
- Another method is known, namely, the Bessey-Lowry method or Huggins-Talalay method, in which a substrate comprising p-nitrophenyl phosphate or phenylphthalein phosphate is reacted with a sample containing phosphomonoesterase, and the liberated p-nitrophenol or phenolphthalein is colorimetrically measured under alkaline conditions.
- this method has disadvantages due to being affected by bilirubin and hemoglobin in the blood.
- a synthetic substrate for assaying phosphate of the formula ##STR7## wherein one of R"' 1 and R"' 2 is ##STR8## and the other is hydrogen, R 20 --O-- is HO-- or a substituted or unsubstituted glycerol residue, and R 3 , R 4 , R 5 and R 6 have the same meanings as hereinbefore.
- phenol compound [I] is liberated from the said synthetic substrate by the enzymatic action of the phosphomonoesterase in the sample, and the phenol compound [I] is colored with a corresponding coupler and oxidase to measure phosphomonoesterase activity.
- Examples of synthetic substrates [VII] can be compounds bound with phenol compound [I] and a mono- or diglyceride phosphate or phosphoric acid, and glycerophosphate or a fatty acid ester substituent thereof. Examples of phenol compound [I] are mentioned hereinbefore.
- Compound [VII] can be synthesized by any conventional synthetic method using phenol compound [I] and phosphoric acid, or glycerophosphate or a fatty acid ester substituent thereof, or a commercially available reagent can also be used. Enzymatic activity can be assayed in a suitable buffer at 37° C. by contacting a sample containing phosphomonoesterase with a synthetic substrate, liberating the phenol compound [I] and measuring the same by a method as set forth hereinbefore.
- phospholipase C As enzymes in phosphodiesterase can be mentioned phospholipase C (EC: 3.1.4.4) and phospholipase D (EC: 3.1.4.4).
- the synthetic substrate therefor is a compound [VII] wherein R 20 --O-- is a substituted or unsubstituted glycerol residue. Examples of substituted glycerol residue are mono- and di-substituted fatty acid esters of glycerol.
- These synthetic substrates can also be used in the same way as in phosphomonoesterase. Phenol compound [I] is rapidly liberated in the case of phospholipase D; however, in the case of phospholipase C, it can be liberated when phosphatase is used jointly with phospholipase C.
- Esterase is an enzyme which hydrolyzes esters of fatty acids and alcohols, or synthesizes the same.
- An enzyme which hydrolyzes esters of lower fatty acids and monohydric alcohols is called esterase in its narrow meaning; and an enzyme which hydrolyzes fatty acid to three molecules of an ester of a higher fatty acid and the trihydric alcohol glycerol, is called lipase.
- lipase in the pancreatic juice or caster oil examples of such enzymes are lipase in the pancreatic juice or caster oil, and esterase in the liver, stomach or serum. Lipase is known as an important enzyme for the diagnosis of pancreatitis in clinical biochemistry.
- a colorimetric assay using synthetic substrate p-nitro phenol acetate, p-nitrophenol laurylate or p-nitrophenol palmitate is one in which enzymatically-liberated p-nitrophenol is measured.
- This method has disadvantages because of the yellow color of the medium, which is affected by pigment (jaundice serum or hemolysate) in the specimen.
- Another method using synthetic substrates for example fatty acid esters of phenol, ⁇ -naphthol or ⁇ -naphthol such as phenol laurylate, ⁇ -naphthol laurylate or ⁇ -naphthyl palmitate, and measuring enzymatically liberated phenol, ⁇ - or ⁇ -naphthol, is known.
- Phenol is measured by the colorimetric method of Folin-Ciocalteau. But this method is quite complex and consumes much time and so is almost never used.
- a further method in which ⁇ -naphthol is reacted with Fast Violet B under alkaline conditions and the thus-formed red color of the diazonium salt is changed to colorless by 2% Triton X-100 solution and is colorimetrically measured at 520 nm.
- ⁇ -naphthol is bound with tetrazo-orthoanisidine to form a red colored insoluble pigment which is extracted with ethyl acetate to measure the same colorimetrically.
- the present assay method is one in which an ester compound of a fatty acid and a phenol compound [I] is used as the synthetic substrate.
- the said substrate has the formula ##STR9## wherein one of R"" 1 and R"" 2 is R 21 --CO--O-- and the other is hydrogen in which R 21 CO-- is a fatty acid residue, and R 3 , R 4 , R 5 and R 6 have the same meanings hereinbefore.
- the said synthetic substrate is hydrolyzed by esterase or lipase in the sample to liberate phenol compound [I], which is oxidatively condensed with a coupler by oxidase.
- the method is preferred for automatic analysis during rate assay and without affecting the contaminant in the serum due to measuring at long wavelength at 500-750 nm.
- the synthetic substrate can be synthesized by any conventional method or can be obtained commercially.
- fatty acids examples include acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecylic acid, lauric acid, tridecanic acid, myristic acid, pentadecanoic acid and palmitic acid. Conventional synthesis methods can be used.
- a buffer solution be used.
- the amount of the synthetic substrate depends upon the amount of the sample, the enzymatic activity and the reaction time and is generally 0.1-20 mM/lit. and 0.01-5 ml.
- the enzymatic reaction is carried out at approximately 37° C. for a sufficient time to liberate amino compound [I] or phenol compound [I], usually more than one minute.
- Amino compound [I] or phenol compound [I] can be measured by the method hereinbefore described.
- the enzymatic reaction for liberating the compound [I] from the substrate, and the measurement for the compound [I] can be performed either separately or preferably in one step by adding previously the necessary reagents and enzyme.
- consumed oxygen can be measured by an oxygen electrode, and automatic rate assay or other colorimetry can be used.
- the reagents and oxidase used in the enzymatic assay can be in liquid form, immobilized form or can be layered on a film or filter paper.
- Non-ionic surface active agents for solubilization and increasing the hydrophilic nature of the synthetic substrate and other stabilizers for oxidase can optionally be added.
- FIG. 1 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, ASOD and 1-naphthol-2-sulfonate (solid line);
- FIG. 2 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, ASOD and phenol (solid line);
- FIG. 3 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, laccase and 1-naphthol-2-sulfonate (solid line);
- FIG. 4 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, laccase and 2,5-dimethylphenol (solid line);
- FIGS. 5 through 52 show the absorption curves (solid line) of pigments indicated in each numbered figure according to the following abbreviations:
- N,N-diethyl-p-phenylenediamine N,N-DEPD
- N,N-DMPD N,N-DMPD
- FIG. 5 2,6-DBAP, laccase and phenol
- FIG. 6 N,N-DEPD, ASOD and phenol
- FIG. 7 N,N-DMPD, ASOD and phenol
- FIG. 8 2,6-DBAP, ASOD and o-methylaniline
- FIG. 9 2,6-DBAP, ASOD and m-methylaniline
- FIG. 10 2,6-DBAP, ASOD and 4-chloro-1-naphthol
- FIG. 11 2,6-DBAP, ASOD and Cleve's acid
- FIG. 12 2,6-DBAP, ASOD and 1-hydroxy-2-naphthoic acid
- FIG. 13 N,N-DEPD, laccase and 1-naphthol-2-sulfonate
- FIG. 14 2,6-DBAP, ASOD and o-chlorophenol
- FIG. 15 2,6-DBAP, ASOD and m-aminophenol
- FIG. 16 2,6-DBAP, ASOD and m-phenylenediamine
- FIG. 17 2,6-DBAP, ASOD and 2,6-dibromophenol
- FIG. 18 2,6-DBAP, ASOD and 2,6-dimethoxyphenol
- FIG. 19 2,6-DBAP, ASOD and 3,5-dimethylphenol
- FIG. 20 2,6-DBAP, ASOD and 2,6-dimethylphenol
- FIG. 21 2,6-DBAP, ASOD and 2,4-dimethylphenol
- FIG. 22 2,6-DBAP, ASOD and 2,3-dimethylphenol
- FIG. 23 2,6-DBAP, ASOD and 2,5-dimethylphenol
- FIG. 24 2,6-DBAP, ASOD and anthranilic acid
- FIG. 25 2,6-DBAP, ASOD and N,N-dimethylaniline;
- FIG. 26 2,6-DBAP, ASOD and aniline
- FIG. 27 2,6-DBAP, ASOD and m-chloroaniline
- FIG. 28 2,6-DBAP, ASOD and o-aminophenol
- FIG. 29 N,N-DEPD, ASOD and o-chlorophenol
- FIG. 30 N,N-DEPD, ASOD and m-phenylenediamine
- FIG. 31 N,N-DEPD, ASOD and o-methylaniline;
- FIG. 32 N,N-DEPD, ASOD and m-methylaniline
- FIG. 33 N,N-DEPD, ASOD and Cleve's acid
- FIG. 34 N,N-DEPD, ASOD and 1-naphthol-2-sulfonate
- FIG. 35 N,N-DEPD, ASOD and 2,6-dibromophenol
- FIG. 36 N,N-DEPD, ASOD and 2,6-dimethoxyphenol
- FIG. 37 N,N-DEPD, ASOD and 2,6-dimethylphenol
- FIG. 38 N,N-DEPD, ASOD and 2,5-dimethylphenol
- FIG. 39 N,N-DEPD, ASOD and N,N-dimethylaniline;
- FIG. 40 N,N-DEPD, ASOD and aniline;
- FIG. 41 N,N-DMPD, ASOD and o-chlorophenol
- FIG. 42 N,N-DMPD, ASOD and 2,6-dibromophenol
- FIG. 43 N,N-DMPD, ASOD and anthranilic acid
- FIG. 44 N,N-DMPD, ASOD and aniline;
- FIG. 45 N,N-DMPD, ASOD and ⁇ -naphthol
- FIG. 46 N,N-DMPD, ASOD and 4-chloro-1-naphthol
- FIG. 47 N,N-DMPD, ASOD and 1-naphthol-2-sulfonate
- FIG. 48 N,N-DMPD, ASOD and m-phenylenediamine
- FIG. 49 N,N-DMPD, ASOD and o-methylaniline
- FIG. 50 N,N-DMPD, ASOD and m-methylaniline
- FIG. 51 2,6-DBAP, ASOD and m-bromoaniline;
- FIG. 52 2,6-DBAP, tyrosinase and N,N-ethyl-hydroxyethylanilin
- FIG. 53 is the standard curve of 2,6-DBAP using 1-naphthol-2-sulfonate and ASOD:
- FIG. 54 is the standard curve of N,N-DEPD using phenol and ASOD;
- FIG. 55 is the standard curve of phenol using N,N-diethyl-p-phenylenediamine and ASOD;
- FIG. 56 is the standard curve of 2,6-DBAP using 2,5-dimethylphenol and ASOD;
- FIG. 57 shows the changes in the absorption curve of pigment at 2-minute intervals during the reaction during ⁇ -glucosidase assay using phenol- ⁇ -glucoside and ASOD;
- FIG. 58 shows the changes in the absorption curve of pigment at 5-minute intervals during the reaction during AlP assay using phenylphosphate and ASOD;
- FIG. 59 shows the changes in the absorption curve of pigment at 2-minute intervals during the reaction during esterase assay using phenyl acetate and ASOD;
- FIG. 60 is a graph of oxygen consumption ratio versus reaction time using 2,6-DBAP, 2,5-dimethylphenol and ASOD;
- FIG. 61 is a graph of oxygen consumption ratio versus reaction time using 2,6-DBAP, 2,5-dimethylphenol and laccase.
- the standard curve for 2,6-dibromo-4-aminophenol was prepared by incubating various concentrations of 2,6-dibromo-4-aminophenol (2 ml), 1-naphthol-2-sulfonate (0.5 mM, 1 ml) and ASOD (100 ⁇ l, 103 U) at 37° C. for 10 mins., and measuring at 630 nm (FIG. 53).
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by phenol (10 mM), but the other operations were performed in the same way.
- the absorption curve of the pigment formed is shown in FIG. 2 (solid line).
- the absorption curve using a 0.1M phosphate buffer (pH 7.0) in place of phenol is shown in FIG. 2 (dotted line).
- 2,6-Dibromo-4-aminophenol can be measured by using ASOD and phenol at 610 nm.
- 2,6-dibromo-4-aminophenol or phenol can be quantitatively determined by the present method.
- 2,6-Dibromo-4-aminophenol hydrochloride was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.5 mM solution (solution A).
- Potassium 1-naphthol-2-sulfonate was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.5 mM solution (solution B).
- Laccase 100 ⁇ l, 80 U obtained from Polyporus versicolor was added to a mixture of solutions A (1.0 ml) and B (1.0 ml) and the resulting mixture was incubated at 37° C. for 24 mins.
- the absorption curve of the generated pigment is shown in FIG. 3 (solid line).
- potassium 1-naphthol-2-sulfonate was replaced by 0.1M phosphate buffer (pH 7.0). (FIG. 3, dotted line).
- 2,6-Dibromo-4-aminophenol can be quantitatively measured at 630 nm using laccase and potassium 1-naphthol-2-sulfonate.
- Example 3 potassium 1-naphthol-2-sulfonate was replaced by 2,5-dimethylphenol (10 mM).
- 2,6-dibromo-4-aminophenol can be assayed by using laccase and 2,5-dimethylphenol.
- Example 3 potassium 1-naphthol-2-sulfonate was replaced by phenol (10 mM).
- phenol or 2,6-dibromo-4-aminophenol can be assayed at 600 nm.
- N,N-diethyl-p-phenylenediamine-dihydrochloride was dissolved in 0.1M phosphate buffer (pH 7.0) to prepare a 1 mM solution (solution A). Phenol was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 10 mM solution (solution B). ASOD (100 ⁇ l, 130 U) was added to the mixture of solution A (1.0 ml) and solution B (1.0 ml) and the mixture was incubated at 37° C. for 20 mins. The absorption curve of the generated pigment is shown in FIG. 6 (solid line). The same reaction, but in which the phenol solution was replaced by a 0.1M phosphate buffer (pH 7.0), was carried out. The results are shown in FIG. 6 (dotted line). As shown by the above, N,N-diethyl-p-phenylenediamine or phenol can be assayed at 670 nm.
- Example 6 N,N-diethyl-p-phenylenediamine dihydrochloride was replaced by N,N-dimethyl-p-phenylenediamine dihydrochloride and the mixture was incubated for 30 mins.
- the absorption curve of the generated pigment is shown in FIG. 7 (solid line). Also, the phenol solution was replaced by a 0.1M phosphate buffer (pH 7.0) (FIG. 7, dotted line).
- N,N-dimethyl-p-phenylene diamine and phenol can be assayed at 655 nm.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by o-methylaniline (0.5 mM).
- FIG. 8 The absorption curve of the generated pigment is shown in FIG. 8 (solid line). Also a test in which o-methylaniline was replaced by 0.1M phosphate buffer (pH 7.0) is shown in FIG. 8 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 670 nm by using ASOD and o-methylaniline.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by m-methylaniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 9 (solid line). Also, a test conducted in which m-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0). The results are shown in FIG. 9 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 670 nm by using ASOD and m-methylaniline.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 4-chloro-1-naphthol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 10 (solid line). Also, the results when 4-chloro-1-naphthol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 10 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 580 nm by using ASOD and 4-chloro-1-naphthol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by Cleve's acid (0.5 mM).
- FIG. 11 The absorption curve of the generated pigment is shown in FIG. 11 (solid line). Also, the results when Cleve's acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 11 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 560 nm by using ASOD and Cleve's acid.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 1-hydroxy-2-naphthoic acid.
- the absorption curve of the generated pigment is shown in FIG. 12 (solid line). Also, the results when 1-hydroxy-2-naphthoic acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 12 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 590 nm by using ASOD and 1-hydroxy-2-naphthoic acid.
- Example 3 2,6-diethyl-p-phenylenediamine.2HCl was replaced by N,N-diethyl-p-phenylenediamine.2HCl (1 mM).
- N,N-diethyl-p-phenylenediamine can be assayed at 660 nm by using laccase and potassium 1-naphthol-2-sulfonate.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by o-chlorophenol (0.1 mM).
- the absorption curve of the generated pigment is shown in FIG. 14 (solid line). Also, the results when o-chlorophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 14 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 650 nm by using ASOD and o-chlorophenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by m-aminophenol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 15 (solid line). Also, the results when m-aminophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 15 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 565 nm by using ASOD and m-aminophenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by m-phenylenediamine (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 16 (solid line). Also, the results when m-phenylenediamine was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 16 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 565 nm by using ASOD and m-phenylenediamine.
- FIG. 17 The absorption curve of the generated pigment is shown in FIG. 17 (solid line). Also, the results when 2,6-dibromophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 17 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 670 nm by using ASOD and 2,6-dibromophenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 2,6-dimethoxyphenol (0.1 mM).
- the absorption curve of the generated pigment is shown in FIG. 18 (solid line). Also, the results when 2,6-dimethoxyphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 18 (dotted line).
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 3,5-dimethylphenol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 19 (solid line). Also, the results when 3,5-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 19 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 620 nm by using ASOD and 3,5-dimethylphenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 2,6-dimethylphenol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 20 (solid line). Also, the results when 2,6-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 20 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 580 nm by using ASOD and 2,6-dimethylphenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 2,4-dimethylphenol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 21 (solid line). Also, the results when 2,4-dimethylphenol was replaced by 0.1M phosphate buffer (pH 7.0) are shown in FIG. 21 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 585 nm by using ASOD and 2,4-dimethylphenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 2,3-dimethylphenol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 22 (solid line). Also, the results when 2,3-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 22 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 590 nm by using ASOD and 2,3-dimethylphenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 2,5-dimethylphenol (10 m).
- the absorption curve of the generated pigment is shown in FIG. 23 (solid line). Also, the results when 2,5-dimethylphenol was replaced by 0.1M phosphate buffer (pH 7.0) are shown in FIG. 23 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 585 nm by using ASOD and 2,5-dimethylphenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by anthranilic acid (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 24 (solid line). Also, the results when anthranilic acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 24 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 640 nm by using ASOD and anthranilic acid.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by N,N-dimethylaniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 25 (solid line). Also, the results when N,N-dimethylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 25 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 700 nm by using ASOD and N,N-dimethylaniline.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by aniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 26 (solid line). Also, the results when aniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 26 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 630 nm by using ASOD and aniline.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by m-chloroaniline (0.5 mM).
- FIG. 27 The absorption curve of the generated pigment is shown in FIG. 27 (solid line). Also, the results when m-chloroaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 27 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 635 nm by using ASOD and m-chloroaniline.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by o-aminophenol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 28 (solid line). Also, the results when o-aminophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 28 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 580 nm by using ASOD and o-aminophenol.
- Example 6 phenol was replaced by o-chlorophenol (0.1 mM).
- FIG. 29 The absorption curve of the generated pigment is shown in FIG. 29 (solid line). Also, the results when o-chlorophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 29 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 690 nm by using ASOD and o-chlorophenol.
- Example 6 phenol was replaced by m-phenylenediamine (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 30 (solid line). Also, the results when m-phenylenediamine was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 30 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 665 nm by using ASOD and m-phenylenediamine.
- Example 6 phenol was replaced by o-methylaniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 31 (solid line). Also, the results when o-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 31 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 700 nm by using ASOD and o-methylaniline.
- Example 6 phenol was replaced by m-methylaniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 32 (solid line). Also the results when m-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 32 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 710 nm by using ASOD and m-methylaniline.
- Example 6 phenol was replaced by Cleve's acid (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 33 (solid line). Also, the results when Cleve's acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 33 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 755 nm by using ASOD and Cleve's acid.
- Example 6 phenol was replaced by potassium 1-naphthol-2-sulfonate (0.5 mM).
- FIG. 34 The absorption curve of the generated pigment is shown in FIG. 34 (solid line). Also, the results when potassium 1-naphthol-2-sulfonate was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 34 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 655 nm by using ASOD and potassium 1-naphthol-2-sulfonate.
- Example 6 phenol was replaced by 2,6-dibromophenol (0.5 mM).
- N,N-diethyl-p-phenylenediamine can be assayed at 700 nm by using ASOD and 2,6-dibromophenol.
- Example 6 phenol was replaced by 2,6-dimethoxyphenol (0.5 mM).
- N,N-diethyl-p-phenylenediamine can be assayed at 630 nm by using ASOD and 2,6-dimethoxyphenol.
- Example 6 phenol was replaced by 2,6-dimethylphenol (10 mM).
- the absorption curve of the generated pigment is shown in FIG. 37 (solid line). Also, the results when 2,6-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 37 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 630 nm by using ASOD and 2,6-dimethylphenol.
- Example 6 phenol was replaced by 2,5-dimethylphenol (10 mM).
- the absorption curve of the generated pigment is shown in FIG. 38 (solid line). Also, the results when 2,5-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 38 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 640 nm by using ASOD and 2,5-dimethylphenol.
- Example 6 phenol was replaced by N,N-dimethylaniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 39 (solid line). Also, the results when N,N-dimethylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 39 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 730 nm by using ASOD and N,N-dimethylaniline.
- Example 6 phenol was replaced by aniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 40 (solid line). Also, the results when aniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 40 (dotted line).
- N,N-diethyl-p-phenylenediamine can be assayed at 690 nm by using ASOD and aniline.
- Example 7 phenol was replaced by o-chlorophenol (0.1 mM).
- FIG. 41 The absorption curve of the generated pigment is shown in FIG. 41 (solid line). Also, the results when o-chlorophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 41 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 680 nm by using ASOD and o-chlorophenol.
- Example 7 phenol was replaced by 2,6-dibromophenol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 42 (solid line). Also, the results when 2,6-dibromophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 42 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 695 nm by using ASOD and 2,6-dibromophenol.
- Example 7 phenol was replaced by anthranilic acid (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 43 (solid line). Also, the results when anthranilic acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 43 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 680 nm by using ASOD and anthranilic acid.
- Example 7 phenol was replaced by aniline.
- the absorption curve of the generated pigment is shown in FIG. 44 (solid line). Also, the results in which aniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 44 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 690 nm by using ASOD and aniline.
- Example 7 phenol was replaced by 2-naphthol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 45 (solid line). Also, the results when 2-naphthol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 45 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 630 nm by using ASOD and 2-naphthol.
- Example 7 phenol was replaced by 4-chloro-1-naphthol (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 46 (solid line). Also, the results when 4-chloro-1-naphthol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 46 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 640 nm by using ASOD and 4-chloro-1-naphthol.
- Example 7 phenol was replaced by potassium 1-naphthol-2-sulfonate (0.5 mM).
- FIG. 47 The absorption curve of the generated pigment is shown in FIG. 47 (solid line). Also, the results when potassium 1-naphthol-2-sulfonate was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 47 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 650 nm by using ASOD and potassium 1-naphthol-2-sulfonate.
- Example 7 phenol was replaced by m-phenylenediamine (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 48 (solid line). Also, the results when m-phenylenediamine was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 48 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 650 nm by using ASOD and m-phenylenediamine.
- Example 7 phenol was replaced by o-methylaniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 49 (solid line). Also, the results when o-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 49 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 695 nm by using ASOD and o-methylaniline.
- Example 7 phenol was replaced by m-methylaniline (0.5 mM).
- the absorption curve of the generated pigment is shown in FIG. 50 (solid line). Also, the results when m-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 50 (dotted line).
- N,N-dimethyl-p-phenylenediamine can be assayed at 705 nm by using ASOD and m-methylaniline.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by m-bromoaniline (0.5 mM).
- FIG. 51 The absorption curve of the generated pigment is shown in FIG. 51 (solid line). Also, the results when m-bromoaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 51 (dotted line).
- 2,6-dibromo-4-aminophenol can be assayed at 635 nm by using ASOD and m-bromoaniline.
- 2,6-dibromo-4-aminophenol hydrochloride was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.05M solution (solution A).
- N,N-ethyl-hydroxyethylaniline was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 5 mM solution (solution B).
- a tyrosinase solution 50 ⁇ l, 100 U was added to a mixture of solution A (1.0 ml) and B (1.0 ml), and the mixture was incubated at 37° C. for 10 mins.
- the absorption curve of the generated pigment is shown in FIG. 52, in which the specific absorption is at 705 nm, and 2,6-dibromo-4-aminophenol can be assayed at 705 nm.
- Pigments showing the same specific absorption was obtained using ASOD and laccase, respectively, in place of tyrosinase.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by m-chlorophenol (0.1 mM).
- the absorption maximum of the generated pigment was at approximately 650 nm.
- 2,6-dibromo-p-aminophenol can be assayed at 650 nm using ASOD and m-chlorophenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by o-chloroaniline (0.5 mM).
- the absorption maximum of the generated pigment was at approximately 630 nm.
- 2,6-dibromo-p-aminophenol can be assayed at 630 nm using ASOD and o-chloroaniline.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by p-chlorophenol (1 mM).
- the absorption maximum of the generated pigment was at approximately 620 nm.
- 2,6-dibromo-p-aminophenol can be assayed at 620 nm using ASOD and p-chlorophenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by p-bromophenol (1 mM).
- the absorption maximum of the generated pigment was at approximately 600 nm.
- 2,6-dibromo-p-aminophenol can be assayed at 600 nm using ASOD and p-bromophenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 2,4-dichlorophenol (0.1 mM).
- the absorption maximum of the generated pigment was at approximately 660 nm.
- 2,6-dibromo-p-aminophenol can be assayed at 660 nm using ASOD and 2,4-dichlorophenol.
- Example 1 potassium 1-naphthol-2-sulfonate was replaced by 2,4-dibromophenol (1 mM).
- the absorption maximum of the generated pigment was at approximately 660 nm.
- 2,6-dibromo-p-aminophenol can be assayed at 660 nm using ASOD and 2,4-dibromophenol.
- Example 6 phenol was replaced by ⁇ -naphthol (0.5 mM).
- the absorption maximum of the generated pigment was at approximately 620 nm.
- N,N-diethyl-p-phenylenediamine can be assayed at 620 nm using ASOD and ⁇ -naphthol.
- Example 6 phenol was replaced by m-chlorophenol (0.5 mM).
- the absorption maximum of the generated pigment was at approximately 695 nm.
- N,N-diethyl-p-phenylenediamine can be assayed at 695 nm using ASOD and m-chlorophenol.
- Example 6 phenol was replaced by 2,3-dimethylphenol (10 mM).
- the absorption maximum of the generated pigment was at approximately 625 nm.
- N,N-diethyl-p-phenylenediamine can be assayed at 625 nm using ASOD and 2,3-dimethylphenol.
- Example 6 phenol was replaced by anthranilic acid (0.5 mM).
- the absorption maximum of the generated pigment was at approximately 680 nm.
- N,N-dimethyl-p-phenylenediamine can be assayed at 680 nm using ASOD and anthranilic acid.
- Example 6 phenol was replaced by 2,4-dimethylphenol (10 mM).
- the absorption maximum of the generated pigment was at approximately 630 nm.
- N,N-diethyl-p-phenylenediamine can be assayed at 630 nm using ASOD and 2,4-dimethylphenol.
- Example 7 phenol was replaced by N,N-dimethylaniline (0.5 mM).
- the absorption maximum of the generated pigment was at approximately 725 nm.
- N,N-dimethyl-p-phenylenediamine can be assayed at 725 nm using ASOD and N,N-dimethylaniline.
- the substrate solution (2 ml), p-xylenol (5 mM, 0.1 ml) and laccase (2000 U/ml, 100 ⁇ l) were mixed in a cell for colorimetry and the mixture was preincubated at 37° C.
- Pregnant serum containing CPA (238 mU/ml) was admixed therein to start the reaction.
- CAP assay can desirably be performed by this method.
- Example 65 N,N-dimethyl-p-phenylenediamine.2HCl was replaced by 3,5-dibromo-4-hydroxyaniline to prepare S-benzyl-L-cysteine-3,5-dibromo-4-hydroxyanilide, and the remaining procedure was conducted the same as in Example 65.
- CAP assay can desirably be performed by this method.
- CAP assay can desirably be performed by this method.
- CAP assay can desirably be performed by this method.
- p-Dimethylaminoaniline.2HCl and N-benzyloxycarbonyl-L-tyrosine were condensed with dicyclohexylcarbodiimide, and the protective group was removed by palladium-carbon catalyst, then the resulting compound was reacted with benzoylchloride to obtain as a synthetic substrate N-benzoyl-L-tyrosinyl-p-dimethylaminoanilide.
- the synthetic substrate (30 mg) was dissolved in acetone (5 ml) to prepare an original substrate solution.
- 0.1M Tris-HCl buffer pH 7.8, 100 ml) (containing 5 mM calcium chloride and 1% Tween 80) was added to the original solution to prepare a substrate solution.
- the substrate solution (2 ml), p-xylenol (15 mM, 0.1 ml) and laccase (2000 U/ml, 100 ⁇ l) were mixed well in a colorimetric cell, and the mixture was preincubated at a constant temperature of 37° C.
- ⁇ -Chymotrypsin (3 mg/ml, 50 ⁇ l) was added thereto to start the reaction.
- ⁇ -chymotrypsin can desirably be assayed by this method.
- N-benzyloxycarbonyl-L-tryptophan and N,N-diethyl-p-phenylenediamine were condensed with dicyclohexylcarbodiimide under ice cooling, and the protective group was removed by palladium-carbon catalyst, then the product was acetylated with acetic anhydride to obtain N-acetyl-L-tryptophan-p-diethylaminoanilide.
- This compound (30 mg) was dissolved in acetone (5 ml) to prepare an original substrate solution.
- 0.1M Tris-HCl buffer pH 7.8, 100 ml, containing 5 mM calcium chloride and 1% Tween 80 was added to prepare the synthetic substrate solution.
- Example 69 p-dimethylaminoaniline 2HCl was replaced by p-diethylaminoaniline to obtain N-benzyl-L-tyrosinyl-p-diethylaminoanilide. This compound (30 mg) was dissolved in acetone (5 ml) to prepare an original substrate solution. The substrate solution was prepared the same way as in Example 69.
- O.D. 655 0.52.
- the substrate solution (2 ml), p-xylenol (5 mM, 0.1 ml) and laccase (2000 U/ml, 100 ⁇ l) were mixed well in a colorimetric cell and the mixture was preincubated at a constant temperature of 37° C.
- ⁇ -Chymotrypsin (3 mg/ml, 50 ⁇ l) was added to start the reaction.
- ⁇ -chymotrypsin can desirably be measured by this method.
- ⁇ -chymotrypsin can desirably be measured by this method.
- Phenyl- ⁇ -D-glucoside (0.24 mM) dissolved in a 0.1M phosphate buffer (pH 7.0, 2 ml), 2,6-dibromo-4-aminophenol (1 mM, 1 ml) and ASOD obtained from Sechium edule (1320 U/ml, 100 ⁇ l) were mixed in a colorimetric cell and preincubated to constant temperature at 30° C.
- ⁇ -Glucosidase Toyobo Co., 3000 U/ml, 10 ⁇ l
- was added thereto to start the reaction, and changes of absorption wavelength were recorded every 2 mins. The result are shown in FIG. 57.
- ⁇ -glucosidase activity can be assayed at 610 nm by reacting with liberated phenol from substrate phenyl- ⁇ -D-glucosidase, ASOD and a coupler.
- a hydroxyl group in maltopentaose was conventionally acetylated with sodium acetate and acetic anhydride.
- the thus-obtained maltopentaose- ⁇ -heptadeca acetate was mixed with phenol and anhydrous zinc chloride to effect a coupling reaction.
- the obtained ⁇ - and ⁇ -phenylhexadeca acetylmaltopentaoside was deacetylated in a sodium methoxide solution in methanol.
- the phenyl hexadecamaltopentaoside thus obtained was dissolved in a 0.05M glycerophosphate buffer (pH 7.0) containing 2% ⁇ -cyclodextrin to prepare a 0.4% substrate solution.
- ⁇ , ⁇ -mixture of o-chlorophenylmaltopentaoside was dissolved in a 0.05M glycerophosphate buffer (pH 7.0) containing 2% ⁇ -cyclodextrin to prepare a 0.4% substrate solution.
- the substrate solution (2 ml), an enzyme solution (50 ⁇ l) containing ⁇ -glucosidase (500 u/ml) and ⁇ -glucosidase (100 U/ml), 2,6-dibromo-4-aminophenol (5 mM, 50 ⁇ l) and laccase (2000 U/ml, 100 ⁇ l) were mixed thoroughly in a colorimetric cell and preincubated at 37° C.
- a hydroxyl group in maltopentaose is acetylated by a conventional method using sodium acetate and acetic anhydride.
- the obtained maltopentaose- ⁇ -heptadeca acetate, 2,6-dibromophenol and anhydrous zinc chloride were conventionally used to effect a coupling reaction to obtain ⁇ - and ⁇ -2,6-dibromophenyl hexadeca acetylmaltopentaoside.
- This product was deacetylated by sodium methoxide in methanol to obtain 2,6-dibromophenylhexadeca maltopentaoside which was dissolved in a 0.05M glycerophosphate buffer (pH 7.0) containing ⁇ -cyclodextrin 2% to prepare a 0.4% substrate solution.
- the substrate solution (2 ml), an enzyme solution (50 ⁇ l) containing ⁇ -glucosidase (500 U/ml) and ⁇ -glucosidase (100 U/ml), 2,6-dibromo-4-aminophenol (5 mM, 50 ⁇ l) and laccase (2000 U/ml, 100 ⁇ l) were mixed thoroughly in a colorimetric cell and preincubated at a constant temperature of 37° C.
- ⁇ -Amylase Boehringer, 5000 I.U./lit., 50 ⁇ l
- ⁇ -amylase can desirably be measured by this method.
- ⁇ -amylase activity can desirably be assayed by this method.
- Phenylphosphate .2Na (5 mM, 2 ml) dissolved in a 0.1M Tris-HCl buffer (pH 8.0), 2,6-dibromo-4-aminophenol (1 mM, 1 ml) and ASOD (1320 U/ml, 100 ⁇ l) obtained from Sechium edule were mixed thoroughly in a colorimetric cell and preincubated at 30° C.
- AlP (Boehringer, 400 U/0.17 ml, 10 ⁇ l) was added thereto to start the reaction, and the changes of absorbency were checked every 5 mins. The results are shown in FIG. 58. AlP activity can be assayed by reacting the liberated phenol from phenylphosphate, ASOD and a coupler.
- 2,6-dibromo phenylphosphate obtained by esterification of a phosphate and 2,6-dibromophenol were dissolved in a 0.1M Tris-HCl buffer (pH 8.0) to prepare a substrate solution (5 mM).
- This substrate solution (2 ml), 2,6-dibromo-4-aminophenol (1 mM, 1 ml) and laccase (2000 U/ml, 100 ⁇ l) were mixed thoroughly in a colorimetric cell and preincubated at 37° C.
- Phenyl acetate (Tokyo Kasei K.K., 5 mM, 1 ml) dissolved in a 0.1M phosphate buffer (pH 7.0), 2,6-dibromo-4-aminophenol (0.5 mM, 1 ml) and ASOD obtained from Sechium edule (60 U/ml, 20 ⁇ l) were mixed thoroughly in a colorimetric cell and preincubated at 30° C.
- Lipase (Toyo Jozo Co., 2545 U/ml, 100 ⁇ l) was added thereto to start the reaction and the changes of absorption every 2 mins. were measured (FIG. 59).
- lipase (esterase) can desirably be assayed by reacting the liberated phenol from substrate phenylacetate, ASOD and coupler.
- Boc-Arg(NO 2 )-OH and N,N-diethylamino-p-phenylenediamine were condensed by a water soluble carbodiimide and the protective group removed to prepare H-Arg (NO 2 )-diethylaminoanilide.
- Boc-Leu-Gly-ester was de-esterified by an alkali to obtain Boc-Leu-Gly-OH.
- Blood lymphocytes (about 100 ml) were collected, carefully avoiding contamination, from Tachypleus tridentatus (about 2 kg weight) (Jap. Pat. Publ. No. 51-40131). Amoebocytes, separated by centrifugation, were washed with 3% aq. NaCl to obtain ameobocyte pellets.
- a buffer solution Tris-HCl 0.05M; CaCl 2 0.001M; NaCl 0.15M; pH 7.2
- ALT Amoebocyte lysate Tachypleus
- This ALT was gel-filtered through Sephadex G-50 (Pharmacia Fine Chem. Co.) according to the method of Young et al. [N. S. Young et al., J. Clin. Invest., 51, 1790 (1972)] to obtain a fraction containing a precursor of amidase, which was treated by endotoxin prepared from Salmonella minesota R595 [M, Niwa et al. Jap. J. Med. Sci. Biol., 26, 20 (1973)] to obtain an endotoxin activation enzyme.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A method for assaying a compound of the formula ##STR1## wherein R1 is hydroxyl or amino, or hydrogen if at least one of R2, R3, R4, R5 and R6 is hydroxyl or amino, and R2, R3, R4, R5 and R6 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxy, carboxyl or sulfo, or R5 and R6 together form a ring, comprises establishing a reaction system containing the compound to be assayed and a coupler and an enzyme capable of consuming oxygen and generating a pigment in the presence of the compound and the coupler. A detectable change in the reaction system is measured, to assay the compound in question. The measurement can comprise the measurement of consumed oxygen, as by an oxygen electrode. Or the measurement can comprise the measurement of the generated pigment, as by a colorimetric assay at a specific absorption wavelength thereof.
Description
This invention relates to a method of assaying a compound of the formula ##STR2## wherein R1 is hydroxyl or amino, or hydrogen if at least one of R2, R3, R4, R5 or R6 is hydroxyl or amino, and R2, R3, R4, R5 and R6 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R5 and R6 together form a ring, which comprises reacting the compound with an oxidase which consumes oxygen and generates a pigment, and measuring at least one of the detectable changes in the reaction system.
The present invention also provides an assay of hydrolase, in which compound [I] is liberated by the action of the hydrolase to be assayed, from a synthetic substrate, which has a component of the structure of compound [I], then oxidizing the thus-produced compound [I] by an oxidase in the presence of a coupler, and measuring the detectable changes.
Enzymatic analysis of a compound in a sample using an enzyme to form a pigment is well known. Most of these methods are assay methods using peroxidase, wherein hydrogen peroxide or phenol, or a compound which generates or liberates the same, is measured.
For example, in an assay of hydrogen peroxide, peroxidase acts in the presence of phenol and a chromogen such as 4-aminoantipyrine, to promote the reaction: H2 O2 →H2 O+[O], in which the phenol and chromogen are oxidatively condensed by the oxidative action of [O] to form a pigment. The amount of hydrogen peroxide can be measured by measuring the absorption at the specific absorption wavelength of the pigment. For example, β-D-glucose forms hydrogen peroxide by the action of glucose oxidase as follows:
β-D-glucose+H2 O+O2 →D-gluconate+H2 O2
The generated hydrogen peroxide is measured and the amount of β-D-glucose can thus be assayed.
This method is the preferred assay method for a reaction system which contains hydrogen peroxide or liberates or generates hydrogen peroxide, and is used in clinical biochemistry.
In the assay of a phenol-series compound, hydrogen peroxide should not be used as a reagent. Since hydrogen peroxide is an unstable compound, assaying a phenol-series compound by this method is not preferred, and in fact is almost unusable.
The enzymatic reaction for forming a pigment other than peroxidase, is that nicotine adenine dinucleotide or nicotine adenine dinucleotide phosphate [NAD(P)] is reduced to NAD(P)H by a dehydrogenase system, and the generated NAD(P) is linked with diaphorase and an electron transfer pigment to form formazane which is then measured by colorimetry. However, this method had disadvantages because the formed formazane is insoluble in water and the pigment adheres to the wall of the container.
We have previously found that p-phenylenediamine or its derivative is oxidized by the action of ascorbate oxidase or laccase to form a pigment, and that leucine aminopeptidase can be assayed by this method. See Japanese Unexam. Pat. Publ. No. 57-115345.
This previous assay method has a number of advantages, such as providing a mild enzymatic assay as compared with chemical methods, and the possibility of automatic rate assay. In this earlier assay method, when a phenol derivative is oxidized by oxidase, the phenol derivative is changed to a compound having an absorption maximum at 350-500 nm.
Quite surprisingly, we have now discovered that a compound of formula [I] and a coupler could be oxidatively condensed by an oxidase such as ascorbate oxidase or laccase, to form a pigment which was previously unknown and which had a different absorption maximum at 500-750 nm.
The compound [I] such as 3,5-dibromo-4-hydroxyaniline does not show color upon reaction with oxidase when a coupler is not used; however, it forms a pigment having an absorption maximum at 600-700 nm by oxidative condensation in the presence of a coupler. This reaction can therefore be considered to proceed by a previously unknown and novel reaction schema.
We have synthesized a synthetic substrate for hydrolase having a component of compound [I], and found that this substrate is hydrolyzed by a corresponding hydrolase to liberate a compound [I] which is changed to a pigment in the presence of a coupler. We have also found that this reaction can be used for the assay of hydrolase.
An object of the present invention is to provide an assay method of a compound [I] which comprises measuring the detectable changes in a reaction system by treating the compound to be assayed with an oxidase which consumes oxygen and generates a pigment in the presence of a coupler.
Another object of the present invention is to provide an assay method of hydrolase which comprises liberating a compound [I] from a synthetic substrate having a component of compound [I] in its structure by the action of hydrolase, treating the thus-produced component with an oxidase which consumes oxygen and generates a pigment in the presence of a coupler, and measuring the detectable changes in the reaction system.
The oxidases are those which consume oxygen and generate a pigment. Examples of the oxidase are ascorbate oxidase, laccase, aminophenol oxidase, polyphenol oxidase and tyrosinase. Preferred examples are ascorbate oxidase obtained from pumpkin, cucumber or chayote (Sechium edule), laccase obtained from a japan (urushi, japanese lacquer), Bacidiomycetes (Coriolus versicolor, Rhizopus or Polyporus versicolor), and tyrosinase. [J. Biochem., 50, 264 (1961), Biochim. Biophys. Acta, 73, 204 (1963), Acta Chem. Scand., 21, 2367 (1967)]. Commercially available enzymes can also be used. These enzymes can be used in the form of immobilized enzymes. The immobilized enzyme can be contacted with an oxygen electrode in an automatic analyzer and the electrochemical changes can be measured. Expensive enzyme can be saved by the use of these electrodes. Furthermore, the sensor, having an enzyme electrode of an immobilized enzyme and an oxygen electrode, can provide an assay method which is rapid, uses less reagent, and can be used for repeated measurements. Also colored specimens can be measured.
The couplers are substances which can oxidatively condense with a compound [I] to form a pigment. In the compound [I] wherein R1 is amino, or hydrogen when at least one of R2, R3, R4, R5 and R6 is amino, and R2, R3, R4, R5 and R6 have the same meanings as hereinbefore (hereinafter called amino compound [I]), the preferred coupler is a compound of the formula ##STR3## wherein R7 is hydroxyl, amino or substituted amino R8, R9, R10, R11 and R12 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R11 and R12 together form a ring.
Examples of the coupler for amino compound [I] are phenol, salicylic acid, m-hydroxybenzoic acid, 2,6-dihydroxybenzoic acid, 2-amino-3-hydroxybenzoic acid, 2-hydroxy-5-aminobenzoic acid, p-hydroxybenzoic acid, methyl salicylate, o-methylphenol, m-methylphenol, p-methylphenol, o-methylphenol, m-methoxyphenol, p-methoxyphenol, o-chlorophenol, m-chlorophenol, p-chlorophenol, 2,3-dimethylphenol, 2,4-dimethylphenol, 2,5-dimethylphenol, 2,6-dimethylphenol, 3,5-dimethylphenol, 2,6-dichlorophenol, o-aminophenol, m-aminophenol, p-bromophenol, o-ethylphenol, m-ethylphenol, 2,4-dichlorophenol, 2,4-dibromophenol, 2,6-dibromophenol, 2,6-dibromo-4-aminophenol, 2,6-dichloro-4-aminophenol, 2,6-dimethoxyphenol, 2-methyl-6-chlorophenol, 2-chloro-5-methylphenol, 2-amino-4-chlorophenol, N,N-diethyl-m-aminophenol, 2-amino-4-methylphenol, o-carboxymethylphenol, 2-carboxy-4-aminophenol, 3,4-dihydroxyphenethylamine, α-naphthol, β-naphthol, 4-chloro-1-naphthol, 2-carboxy-1-naphthol, 1-hydroxy-2-naphthoic acid, 1-naphthol-2-sulfonate, 1-naphthol-3-sulfonate, 1-naphthol-4-sulfonate, 1-naphthol-8-sulfonate, 2-naphthol-6-sulfonate, 2-naphthol-7-sulfonate, 2-naphthol-8-sulfonate, 2-naphthol-3,6-disulfonate, 2-naphthol-6,8-disulfonate, N,N-diethyl-m-aminoaniline, N,N-dimethyl-m-aminoaniline, o-carboxyaniline, m-carboxyaniline, o-chloroaniline, m-chloroaniline, m-bromoaniline, o-methylaniline, m-methylaniline, N,N-dimethylaniline, N,N-diethylaniline, N,N-ethyl.ethylhydroxyaniline, N,N-ethyl.ethylhydroxy-m-toluidine, 3-amino-4-chloroaniline and 2-methyl-3-chloroaniline.
In the compound [I] wherein R1 is hydroxyl, or hydrogen when at least one of R2, R3, R4, R5 and R6 is hydroxyl, and R2, R3, R4, R5 and R6 have the same meanings as hereinbefore (hereinafter called phenol compound [I]), the preferred coupler is a compound of the formula ##STR4## wherein R13 is amino or substituted amino, and R14, R15, R16, R17 and R18 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R17 and R18 together form a ring. Examples of couplers for phenol compound [I] are N-ethylaniline, N,N-dimethylaniline, N,N-diethylaniline, N,N-dimethyl-o-toluidine, N,N-dimethyl-p-toluidine, N,N-diethyl-o-toluidine, N,N-diethyl-m-toluidine, N,N-diethyl-p-toluidine, anthranylic acid, p-dimethylaminobenzoic acid, p-chloro-o-toluidine, m-phenylenediamine, p-phenylenediamine, aniline, o-methylaniline, m-methylaniline, o-carboxyaniline, o-chloroaniline, m-chloroaniline, m-bromoaniline, 2-methyl-5-carboxyaniline, N,N-ethyl-hydroxyethylaniline, N,N-dimethyl-m-phenylenediamine, N,N-dimethyl-p-phenylenediamine, N,N-diethyl-p-phenylenediamine, 2-methyl-m-phenylenediamine, 4-methyl-o-phenylenediamine, 4-methyl-m-phenylenediamine, 2-methoxy-5-chloroaniline, 2-ethylaniline, N,N-dimethyl-m-toluidine, 2-chloro-m-phenylenediamine, 2-methyl-3-chloroaniline, 2,5-dimethoxyaniline, 1-amino-5-naphthalenesulfonate, 1-amino-5-naphthalenesulfonate, N,N-ethyl.ethylhydroxy-m-toluidine, 3,5-dibromo-4-hydroxyaniline, 3,5-dichloro-4-hydroxyaniline, o-hydroxyaniline, m-hydroxyaniline, 2-amino-N,N-dimethylaniline, p-N,N-diethylaminoaniline, 2-methyl-3-aminoaniline, 2-methyl-5-aminoaniline, 3-carboxyaniline, 3-carboxy-4-hydroxyaniline and 2-methyl-5-carboxyaniline.
Examples of amino compound [I] are 4-hydroxy-3,5-dichloroaniline, 4-hydroxy-3,5-dibromoaniline, p-N,N-diethylaminoaniline, p-N,N-dimethylaminoaniline, m-phenylenediamine, p-phenylenediamine, o-aminophenol, m-aminophenol, aniline, o-toluidine, m-toluidine, o-carboxyaniline, o-chloroaniline, m-chloroaniline, m-bromoaniline, m-N,N-dimethylaminoaniline, 2-chloro-5-aminoaniline, 2-methyl-3-chloroaniline, 2,5-dimethoxyaniline, 2-methyl-3-aminoaniline, 2-methyl-5-aminoaniline, 2-methyl-5-carboxyaniline, 2-hydroxy-6-carboxyaniline, 2-hydroxy-5-methylaniline, 3-carboxyaniline, 2-carboxy-4-hydroxyaniline, 2-hydroxy-5-chloroaniline, o-ethylaniline, 2-methyl-5-carboxyaniline, 1-amino-6-naphthol-sulfonate and 3-amino-4-chloroaniline.
Examples of phenol compound [I] are 4-amino-2,6-dichlorophenol, 4-amino-2,6-dibromophenol, o-aminophenol, m-aminophenol, p-aminophenol, m-carboxyphenol, p-carboxyphenol, phenol, o-chlorophenol, m-chlorophenol, p-chlorophenol, p-bromophenol, o-ethylphenol, m-ethylphenol, o-methylphenol, m-methylphenol, p-methylphenol, o-methoxyphenol, salicyclic acid, methylsalicylate, o-carboxymethylphenol, m-N,N-diethylaminophenol, 2,4-dichlorophenol, 2,4-dibromophenol, 2,6-dibromophenol, 2,6-dimethoxyphenol, 3,5-dimethylphenol, 2,5-dimethylphenol, 2,4-dimethylphenol, 2,3-dimethylphenol, 2,6-dimethylphenol, 2-methyl-5-chlorophenol, 2-chloro-5-methylphenol, 2-amino-3-carboxyphenol, 2-amino-4-methlylphenol, 2-carboxy-4-aminophenol, 2-amino-4-methylphenol, 2-carboxy-4-aminophenol, 2-amino-4-chlorophenol, α-naphthol, β-naphthol, 4-chloro-1-naphthol, 2-carboxy-1-naphthol, 1-naphthol-2-sulfonate, 1-naphthol-3-sulfonate, 1-naphthol-4-sulfonate, 1-naphthol-8-sulfonate, 2-naphthol-6-sulfonate, 2-naphthol-8-sulfonate, 2-naphthol-3,6-disulfonate, and 8-hydroxy-quinoline-5-sulfonate. Examples of amino compound [I] or phenol compound [I] having both amino and hydroxyl are o-, m- or p-aminophenol, 2-chloro-4-aminophenol, 2-amino-4-carboxyphenol, 2-amino-4-methylphenol, 2-carboxy-4-aminophenol, 2-amino-4-chlorophenol, 2,6-dichloro-4-aminophenol and 2,6-dibromo-4-aminophenol.
Any couplers for amino compound [I] or phenol compound [I] can be used as the aminophenol series compounds hereinabove; however, when the coupler and the aminophenol compound are identical, these combinations of the coupler and the aminophenol compound should be excluded.
In the assay of the compound of formula [I] (hereinafter called compound [I]), a sample containing compound [I] is treated with oxidase which consumes oxygen and generates a pigment in the presence of a coupler [IV]. The amount of coupler used is equimolar or an excess for compound [I], and is an amount having a non-inhibitory action toward the enzyme. These couplers should be prepared for use in constant concentration in a buffer solution of neutral pH, such as Tris-HCl, phosphate, dimethylglutarate-NaOH, acetate, imidazole-HCl, Pipes-NaOH or citrate buffer. The amount of enzyme used is generally (for 0.1-5 ml of 0.1 mM/lit. of compound [I]) ascorbate oxidase 10-1000 units, preferably 50-200 units and laccase or tyrosinase 10-1000 units, preferably 50-500 units. The reaction temperature is about 25°-40° C., preferably about 37° C. The reaction time varies depending on the amount of enzyme used, the temperature and the assay procedure, and is generally more than one minute. Rate assay can preferably be performed in one minute and the other colorimetric assay is preferably performed in 5 minutes.
After the reaction is complete, at least one of the detectable changes is measured, and this is performed by measuring the amount of consumed oxygen or the generated pigment. Oxygen can be measured by electrochemical means such as an oxygen electrode. The amount of oxygen can be measured by colorimetry at 500-750 nm maximum absorption wavelength. The amount of compound [I] in the sample can be measured by calculation from a standard curve.
For the assay of compound [I], a synthetic substrate having a component of that compound [I] in its structure can also be assayed.
The synthetic substrate should be a substrate for hydrolase such as peptidase, protease, amylase, glycosidase, phosphatase, esterase or lipase. Further preferred hydrolases are commercially available enzymes, cultured broths containing enzymes, and specimens such as cells, tissues, urine, saliva and serum. In the present invention, a sample containing the hydrolase is mixed with a corresponding synthetic substrate, and the mixture is incubated at 37° C. to liberate the compound [I]. This compound [I] is treated with an oxidase which consumes oxygen and generates a pigment in the presence of a coupler as hereinbefore, to permit assay of the activity of the enzyme in the sample.
Embodiments of enzyme to be assayed, synthetic substrates and their production are illustrated as follows:
1) Peptidase and protease:
Among the peptidases, aminopeptidase has been known generically as an enzyme which acts on peptide chains to split the amino terminal and liberate amino acids or peptides. Examples of aminopeptidase are cysteine-aminopeptidase (EC: 3. 4. 11. 3), proline aminopeptidase (EC: 3. 4. 11. 5), arginine aminopeptidase (EC: 3. 4. 11. 6), tripeptide aminopeptidase (EC: 3. 4. 11. 4), X-prolyl dipeptidylaminopeptidase (wherein X is an acidic, neutral or basic amino acid residue), and dipeptidase (EC: 3. 4. 13. 11).
Cysteine aminopeptidase (hereinafter called CAP) is found in increased quantity in the blood during an abnormal pregnancy, and an assay of CAP is useful for diagnosis of the placental function and is used for checking a clinical diagnosis during the period of pregnancy.
Synthetic substrate S-benzyl-L-cysteinyl-p-nitroanilide or S-benzyl-L-cysteinyl-N,N-dimethylaminoanilide has been used for that assay. CAP activity is assayed by measuring the yellow color of the p-nitroaniline liberated from substrate S-benzyl-L-cysteinyl-p-nitroanilide. Measuring the yellow color thereof is effected by bilirubin serum or hemolytic serum. Furthermore, liberated p-nitroaniline is chemically reacted with p-dimethylamino cinnamaldehyde to form a red pigment which is measured at 565 nm. This method is impossible to use for rate-assay. Enzymatic activity is also assayed by measuring the blue-green color formed during the reaction of p-dimethylaminoaniline liberated from S-benzyl-L-cystenyl-p-dimethylaminoanilide by the action of CAP and an iron-complex reagent. This method is also impossible to use for rate assay, for chemical reasons.
In the present invention, a synthetic substrate is used, which is a compound having a component of amino compound [I] in its structure, obtained by reacting its amino group with the carboxyl group of an amino acid or peptide.
This synthetic substrate has the formula ##STR5## wherein one of R'1 and R'2 is R19 CO--NH-- and the other is hydrogen, R19 CO-- is an amino acid residue or peptide residue, and R3, R4, R5 and R6 have the same meanings as hereinbefore.
Examples of the R19 CO-- group are S-benzyl-L-cystenyl, L-alanyl and X-prolyl, wherein X is an acidic, neutral or basic amino acid residue.
A sample containing peptidase is reacted with a synthetic substrate of the formula [V] to liberate an amino compound [I] which is subjected to oxidative condensation with a corresponding coupler by oxidase. The resultant mixture is colorimetrically measured at 500-750 nm. The method hereinabove is the preferred method for automatic rate assay.
A synthetic substrate [V] can be produced by conventional peptide synthesis, for example by the condensation of S-benzyl-L-cysteine and an amino compound [I]. S-benzyl-L-cystein can be obtained by the benzylation of the thiol group in L-cysteine. In this synthesis, the functional group is protected if necessary. Protection is performed by any conventional method of peptide synthesis. For example, the α-amino group in L-cysteine is protected by a conventional protective group such as t-butoxycarbonyl, t-amyloxycarbonyl, benzyloxycarbonyl, adamantanyloxycarbonyl or o-nitrophenyl-thionitro-substituted benzyloxycarbonyl. The α-carboxyl group of S-benzyl-L-cysteine, wherein the α-amino group is protected, is activated for example by converting to an acid azide, acid anhydride, acid halogenide, acid imidazolide or activated ester, or by treating with carbodiimide, N,N-carbonyldiimidazole or an isoxazolium salt such as Woodward reagent.
The activated compound is reacted with an amino compound [I], preferably by the carbodiimide, azide, acid halogenide, activated ester or acid anhydride method. The reaction is carried out in an inert solvent such as dimethylformamide, dimethylacetamide dimethylsulfoxide, tetrahydrofuran, benzene, xylene, toluene or diethyl ether at -30° C. to room temperature, generally for 30 minutes to 50 hours, at an equimolar ratio of both compounds. After the reaction is complete, the protective group for the α-amino group is removed. For example, t-butoxycarbonyl is removed by 2N-hydrogen chloride in acetic acid or trifluoroacetic acid, and benzyloxycarbonyl is removed by catalytic hydrogenation using palladium-carbon or hydrogen bromide in acetic acid.
If the amino compound is a liquid, it can be used as the reactive liquid medium, or benzene can be used. The reaction proceeds at 50°-100° C. for 20 minutes to 5 hours.
The thus-obtained synthetic substrate can be purified by conventional extraction, washing, chromatography or otherwise. The product can also be prepared as its salt by reacting with an inorganic acid such as hydrochloric, hydrobromic or phosphoric, or an organic acid such as formic, acetic, propionic, or oxalic.
The enzymatic activity in a specimen such as serum can be assayed by adding a synthetic substrate in a buffer solution, and reacting the liberated amino compound [I] with a coupler in the presence of an oxidase.
X-prolyl-dipeptidyl-aminopeptidase (hereinafter called X-PDAP) wherein X is an amino acid residue, especially glycylprolyl-dipeptidyl aminopeptidase (hereinafter called GPDAP) is a dipeptidylaminopeptidase which hydrolyzes the N-terminal of peptides to liberate glycylproline.
Serum X-PDAP activity increases in acute or chronic hepatitis, hepatocirrhosis or tumor of the bile duct, and decreases in gastric tumor such as stomach cancer or pancreatic tumor. Assaying X-PDAP is useful for the diagnosis of gastric tumor.
Heretofore, synthetic substrates have been used, wherein X is glycine, for example (1) Gly-L-Pro-α-naphthylamide, (2) Gly-L-Pro-p-nitroanilide, (3) Gly-L-Pro-p-phenylazoanilide or (4) 7-(Gly-L-Pro)-4-methylcoumarinamide. For example, an assay method using (1) is a method in which enzymatically-liberated α-naphthylamine is chemically colored by 3-methyl-2-benzothiazolynone hydrazone (MBTH)-FeCl3 and colorimetrically measured. However, α-naphthylamine has carcinogenicity and so is not hygienically safe. The method using (2) is a colorimetric method of measuring liberated yellow-colored p-nitroaniline, and is adversely affected by bilirubin serum or hemolytic serum. Methods using (3) and (4) also have disadvantages.
The present synthetic substrate is a compound wherein the amino group in amino compound [I] is combined with an X-L-prolyl group. Examples of group X are amino acid residues, for example neutral amino acids such as glycine or alanine, acidic amino acids such as aspartic acid or glutamic acid, or basic amino acids such as lysine or arginine. Any type of L-, D- or Dl-amino acid can also be used. A synthetic substrate dipeptide derivative can be used as the free base or as its salt such as p-toluenesulfonate, hydrochloride or hydrobromide. Preferred dipeptide derivatives are compounds wherein X is a neutral or basic amino acid; and dipeptides wherein X is an acidic amino acid are less hydrolyzed.
The present synthetic substrate can be synthesized by any conventional peptide synthesis. For example, the protective group of N-protected-X-prolyl-amino compound [I] is removed. N-protected amino acid-L-prolyl-amino compound [I] is synthesized by reacting an L-prolyl-amino compound [I] with an N-protected amino acid using a condensing reagent such as carbodiimide, or by the activated ester method using an N-protected amino acid having an activated carboxyl group. The protective group can be selected from conventional preferred protective groups, for example benzyloxycarbonyl, t-butyloxycarbonyl, t-amyloxycarbonyl or formyl. The functional side group, if any, is previously protected by any conventional method. For example, the side chain carboxy group in acidic amino acid is protected by a benzyl ester. The guanidino group in arginine is protected by any conventional protective group such as tosyl, nitro, p-nitrobenzyloxycarbonyl or 2-(isopropyloxycarbonyl)-3,4,5,6-tetrachlorobenzoyl, preferably tosyl or nitro. The N-ε-amino group in lysine is preferably protected by any conventional protective group for an α-amino group. The protective group of an N-protected-X-L-prolyl-amino compound [I] is removed by any conventional method. Selective removal of the protective group should be performed. Dipeptide derivatives can also be obtained by a method wherein previously-synthesized N-protected-X-L-proline is condensed with an amino compound [I] to obtain an N-protected-X-L-prolyl-amino compound [I]; then the protective group is removed.
Protease is a general term for enzymes which hydrolyze peptide bonds of peptides and proteins. Examples are pepsin, trypsin, α-chymotrypsin, microbial protease, thrombin, plasmin, plasma kallibrein tissue kallikrein, urokinase, factor Xa, collagenase, elastase or cathepsin.
The diagnostically important proteinases are trypsin and α-chymotrypsin for pancreatic function and protease for the clotting system or fibrinolytic system such as plasmin, thrombin, plasma kallitrein, tissue kallikrein, urokinase or factor Xa.
Heretofore, chromogenic peptide derivatives have been used as synthetic substrates for these assays. For example, the following substrates can be mentioned:
Substrates for thrombin:
Bz-Phe-Val-Arg-p-nitroanilide.HCl,
H-D-Phe-Pro-Arg-p-nitroanilide.HCl,
Tos-gly-Pro-Arg-p-nitroanilide.HCl,
Boc-Val-Pro-Arg-methylcoumarinamide,
H-D-Phe-Pro-Arg-aminoisophthalate dimethyl ester.
Substrates for factor Xa:
Bz-Ile-Glu-Gly-Arg-p-nitroanilide.HCl,
Boc-Ile-Glu-Gly-Arg-methylcoumarinamide.
Substrates for plasma kallikrein:
Bz-Pro-Phe-Arg-p-nitroanilide.HCl,
H-D-Pro-Phe-Arg-p-nitroanilide.2HCl,
Z-Phe-Arg-methylcoumarinamide.
Substrates for plasmin:
H-D-Val-Leu-Lys-p-nitroanilide.2HCl,
Tos-Gly-Pro-Arg-p-nitroanilide.HCl,
Boc-Glu-Lys-Lys-methylcoumarinamide,
Boc-Val-Leu-Lys-methylcoumarinamide,
H-D-Val-Leu-Lys-aminoisophthalate dimethyl ester.
Substrates for urokinase:
Bz-Val-Gly-Arg-p-nitroanilide HCl,
Pyro-Glu-Gly-Arg-p-nitroanilide.HCl,
Glutaryl-Gly-Arg-methylcoumarinamide.
Substrates for tissue kallikrein:
H-D-Val-Leu-Arg-p-nitroanilide.2HCl,
H-Pro-Phe-Arg-methylcoumarinamide.
As for the assay method, liberated p-nitroaniline, aminomethylcoumarin or aminoisophthalate dimethyl ester can be measured by the action of an enzyme in the specimen. In these methods, liberated p-nitroaniline shows a yellow color and is disadvantageously affected by, for example, jaundice color or hemolytic red color. Aminomethylcoumarin or aminoisophthalate dimethyl ester is measured by fluorometry and hence is disadvantageously affected by serum component. In order to avoid these disadvantages, a deproteinization procedure is required. The substrates for trypsin and chymotrypsin are generally acyl-basic amino acid- or acyl-aromatic amino acid-p-nitroanilide. p-Nitroaniline liberated therefrom is measured for assaying these enzymes. Similar disadvantages are found.
In the present invention, a compound of formula [V] hereinbefore, for example an acyl-basic amino acid (peptide having C terminal basic amino acid)-amino compound [I] or an acyl-aromatic amino acid-amino compound, is used as the synthetic substrate, and an amino compound [I] is liberated from this synthetic substrate by the action of trypsin, chymotrypsin or protease (an enzyme acting on the blood clotting system and fibrinolytic system) in the specimen. The liberated amino compound [I] is oxidatively condensed in the presence of a coupler by an oxidase, and the pigment formed is colorimetrically measured. The method is advantageously automated for rate-assay and is not affected by serum components because it has a specific absorption maximum wavelength at 500-750 nm.
Preferred examples of acyl-basic amino acids in synthetic substrates for these enzymes are as follows:
For thrombin:
Bz-Phe-Val-Arg-OH
H-D-Phe-Pro-Arg-OH
Tos-Gly-Pro-Arg-OH
Boc-Val-Pro-Arg-OH
H-D-Pro-Arg-OH
For factor Xa:
Bz-Ile-Glu-Gly-Arg-OH
Boc-Ile-Glu-Gly-Arg-OH
For plasma kallikrein:
Bz-Pro-Phe-Arg-OH
H-D-Pro-Phe-Arg-OH
Z-Phe-Arg-OH
For plasmin:
Tos-Gly-Pro-Arg-OH
Boc-Glu-Lys-Lys-OH
Boc-Val-Leu-Lys-OH
H-D-Val-Leu-Lys-OH
For urokinase:
Bz-Val-Gly-Arg-OH
Pyro-Glu-Gly-Arg-OH
Glutaryl-Gly-Arg-OH
For tissue kallkrein:
H-D-Val-Leu-Arg-OH
Pro-Phe-Arg-OH
Synthetic substrates having these components can also be produced in the same way as illustrated in connection with CAP and GPDAP hereinbefore. An example of synthesis of an amino compound [I] having N,N-diethylamino-p-phenylenediamine is as follows:
Boc-Arg(NO2)-OH and N,N-diethylamino-p-phenylenediamine (DEAA) are condensed by a water soluble carbodiimide (WSC) to obtain Boc-Arg(NO2)-DEAA. The tert-butyloxycarbonyl group (Boc-) is hydrated by HCl/ethyl acetate to obtain H-Arg(NO2)-DEAA. The obtained H-Arg(NO2)-DEAA and the amino-group-protected peptides are condensed in the same way as for CAP or GPDAP, for example by dehydration condensation in the presence of WSC in butanol, and the NO2 group is removed by catalytic reduction with palladium/carbon to obtain an acylated basic amino acid-amino compound [I].
The compound [V] can be used for the detection of bacterial endotoxin. Heretofore, trace analysis of bacterial endotoxin using the phenomenon of gelation by amoebocyte lysate of horseshoe crabs and a trace amount of bacterial endotoxin, has been performed.
Recently, endotoxin has been used in clinical pathology. For example, a lymrus amoebocyte lysate test in the surgical field is used for clinical diagnosis of disease findings of exogenous endotoxemia or endotoxin shock caused by diseases showing an apparent infectious nidus. In the field of internal medicine, the effect of intestinal Gram negative bacterial endotoxin on hepatopathy and endogenous endotoxemia, for example the decrease of recticuloendotherial system functions such as detoxication of bacterial endotoxin in the liver, are a problem. For these purposes, the clinical determination of endotoxin on blood clotting, the fibrinolystic system, the kinin system, the circulatory system and the immune system has become important.
In the assay of the above bacterial endotoxin, specimens such as the patient's body fluids, especially blood, ascites, urine, pancreatic juice, liquor cerebrospinalis or bile, are used. These body fluids, however, have their own color, and these colors and the pigments caused by diseases such as the jaundice deep yellow color and the hemolytic red color, inhibit colorimetry. Furthermore, body fluids contain fluorescent substances and hence fluorometry may be inhibited.
In the present assay method, a synthetic substrate of compound [V] wherein R19 CO-- is R'19 -Gly-Arg, in which R'19 is an L-amino acid residue or a peptide residue having a protected N-terminal, and amoebocyte lysate and/or an enzyme precursor isolated therefrom, are reacted with a specimen containing bacterial endotoxin to liberate an amino compound [I]. The amino compound [I] is oxidatively condensed with a coupler by oxidase to colorimetrically assay the endotoxin. The said colorimetric assay can be carried out at 500-750 nm and is preferred for rate assay in an automatic analysis without being inhibited by contaminants in the specimen serum.
Amoebocyte lysate can be obtained by the hypotonic treatment of amoebocytes in the lymphocytes of horseshoe crabs, or as a commercial product (LAL-test; lymus amoebocyte lysate test). Commercially available products are, for example Pregel (Difco Lab., U.S.A.) and Pyrogent (Mallinckrodt Inc., U.S.A.)
The isolation and purification of the enzyme precursor can be effected by treating an amoebocyte lysate by column chromatography, electrophoresis, electrofocusing or affinity chromatography.
The amoebocyte lysate or the enzyme precursor separated therefrom is activated by bacterial endotoxin to form an active enzyme which acts specifically on a peptide of synthetic substrate [V], wherein R'19 is, for example Boc-Leu-, Boc-Val-Leu-, Boc-Ser-, Boc-Val-Ser-, Bz-Leu-, Bz-Val-Leu-, Bz-Ser- or Bz-Val-Ser-. Synthesis of the substrate can be performed by the same method as illustrated for the protease hereinbefore.
(2) Sugar hydrolase (amylase, glycosidase):
Examples of sugar hydrolase are amylase, dextranase (EC: 3.2.1.11), cellulase (EC: 3.2.1.4) and glycosidase.
Amylase can be classified as α-amylase (EC: 3.2.1.1), β-amylase (EC: 3.2.1.2) or γ-amylase (EC: 3.2.1.3). α-amylase splits the α[1→4]-linkage between the glucose moiety in starch or lower a polymerized glucose and the oligomer. The said enzyme is originally produced in the pancreas and salivary gland, and increases due to acute pancreatitis. Assaying α-amylase is therefore an important clinical diagnostic procedure.
Various methods of assaying amylase activity are known. The blue starch method is a widely used method in which the blue color liberated by amylase action is colorimetrically assayed. In this method, the substrate is insoluble in water and filtration is essential for colorimetry but is undesirable for an automatic procedure. Furthermore, an assay method using a synthetic substrate for amylase is known. This latter method comprises reacting a synthetic substrate p-nitrophenylmaltopentaoside with α-amylase, liberating p-nitrophenyl by action of α-glucosidase and measuring the same by colorimetry. But this method is disadvantageous for assaying serum amylase because the reaction mixture is yellow, like bilirubin serum or hemolyzate. Another method, in which a synthetic substrate comprising 2,5-dichlorophenylmaltopentaoside is reacted with α-amylase, and further is treated with α-glycosidase and β-glycosidase to liberate 2,4-dichlorophenol which is oxidatively condensed with 4-aminoantipyrine by sodium periodate, with measurement of the absorbency at 500 nm, is known. This method is also disadvantageous because it is impossible to use in an automatic assay system.
The present invention is an improved assay method which is also advantageous for automatic rate assay.
In the amylase assay of the present invention, a synthetic substrate is used which is prepared by condensing a hydroxyl group of a malto-oligosaccharide and a phenolic hydroxyl group of a phenol compound [I]. The synthetic substrate is hydrolyzed by amylase at the malto-oligosaccharide moiety to liberate the phenol compound [I] in combination with glucoside, maltoside or maltopentaoside, which is treated with α- and β-glucosidase to form the phenol compound [I]. The liberated phenol compound [I] is measured colorimetrically.
Malto-oligosaccharides used in the present invention include saccharides consisting of 2-10 D-glucose with an α-1,4-glucoside bond. Examples are maltose, maltotriose, maltotetraose, maltopentaose and maltohexaose. Maltotetraose, maltopentaose and maltohexaose of the formula [VI] hereinbelow are preferred.
Examples of phenol compound [I] are compounds having α- or β-linkage with malto-oligosaccharide or its reduced terminal, which are easily hydrolyzed by α-glucosidase or β-glucosidase and are easily measurable. The said phenol compound [I] includes aminophenol series compounds as set forth hereinbefore.
The synthetic substrate of the present invention is a compound of the formula ##STR6## wherein one of R"1 and R"2 is (S)n-O- and the other is hydrogen, S is a monosaccharide unit, n is an integer greater than one, and R3, R4, R5 and R6 having the same meanings as hereinbefore. A compound wherein (S) is a glucose moiety and n=2-8 to preferred.
The synthetic substrate [VI] is prepared by the conventional synthetic method with a malto-oligosaccharide. For example, a malto-oligosaccharide is acetylated, and acetyl maltooligosaccharide is condensed with phenol compound [I], then the resulting compound is deacetylated to prepare the product. [Experimental Chemistry, Vol. 24, p. 304 (1958), in Japanese].
Compound [VI] can also be obtained by the enzymatic reaction of phenol compound [I]-α-D-glucoside having one glucosyl group and maltodextrin by cyclomaltodextrin-gluconotransferase; EC: 2.4.1.19. [Wallenfels et al., Carbohydrate Res., 61, 359 (1978)]. By this method, a compound [VI] wherein n=2-8 is obtained which is purified by any conventional method.
Serum amylase is assayed by incubating the enzyme and a synthetic substrate, and α-glucosidase, if required with β-glucosidase, in a buffer solution, and measuring the thus-liberated phenol compound [I] with a coupler and an oxidase.
Examples of glucosidase to be assayed are α-glucosidase (EC: 3.2.1.20), β-glucosidase (EC: 3.2.1.21), α-galactosidase (EC: 3.2.1.22), β-galactosidase (EC: 3.2.1.23), α-mannosidase (EC: 3.2.1.24), β-mannosidase (EC: 3.2.1.25), β-glucuronidase (EC: 3.2.1.31), β-xylosidase (EC: 3.2.1.37), α-L-fusocidase (EC: 3.2.1.51), α-N-acetylgalactosaminidase (EC: 3.2.1.49), α-N-acetylglucosaminidase (EC: 3.2.1.50), β-N-acetylgalactosaminidase (EC: 3.2.1.53), and β-N-acetylglucosaminidase (EC: 3.2.1.30).
Their enzymatic activity can be measured by using a synthetic substrate [VI] wherein the monosaccharide moiety [S] is a pentose, hexose, hexosamine or uronic acid unit, and n=1. For example, a pentose unit such as a xylose unit, a hexose unit such as glucose unit, a galactose unit, a mannose unit or a fucose unit, a hexosamine unit such as an N-acetylgalactosamine unit or an N-acetylglucosamine unit and a uronic acid unit such as glucuronic acid can be mentioned. Glucosidase can be assayed by liberating a phenol compound [I] from a synthetic substrate by the action of the corresponding glucosidase, and measuring the phenol compound [I] with a coupler and an oxidase. For example, a commercially available substrate for glucosidase, phenyl-β-D-glucoside, is contacted with a sample containing glucosidase in a suitable buffer at 37° C., and liberated phenol is converted to a coloring substance with the corresponding coupler and oxidase.
(3) Phosphatase:
Phosphatase is an enzyme which catalyzes the hydrolysis of phosphate esters, and undergoes not only hydrolysis but also a reversible reaction, the direction of the reaction depending on the relative concentration of substrate and product.
In the human body, many phosphate ester compounds are known. The phosphatases which participate in the metabolism of these phosphate esters are classified according to the bond site of the substrate, i.e:
(1) phosphomonoesterase;
(2) phosphodiesterase;
(3) pyrophosphatase;
(4) metaphosphatase;
(5) polyphosphatase;
(6) phosphoamidase.
In clinical tests, phosphomonoesterase is used. Phosphomonoesterase hydrolyzes nonspecifically phenylphosphate, p-nitrophenylphosphate or β-glycerosphosphate. In general, the enzyme having optimum pH on the alkaline side is designated as alkaline phosphatase (EC: 3.1.3.1) (hereinafter called AlP) and that on the acidic side is called acid phosphatase (EC: 3.1.3.2) (hereinafter ACP).
Most AlP originates from the bones, liver, placenta, small intestine or mucosa; and since it is mainly located in the cell membranes, the enzyme participates in active transport through membranes, namely, metabolism.
Diseases is which serum AlP increases are known, such as rachitis, osteomalacia, diaclasis, hepatopathy, cholangitis or tumor, and the assay of serum AlP is important for clinical diagnosis of these maladies. Serum ACP assay is mainly used for the diagnosis of prostatic cancer, and is said to show some effect on the metastasis of mammary cancers.
Heretofore, phosphatase has been assayed by a method of measuring liberated phosphate after hydrolysis of an organic phosphate ester, and a method of measuring liberated phenol from a substrate which is an organic phosphate ester of a phenol.
But the method measuring phosphate is disadvantageous, because coexisting phosphate in the specimen is simultaneously measured and so inorganic phosphates in sample have to be measured and eliminated. Furthermore, the reaction time is very long, and deproteination is required.
A method measuring phenols, the Kind-King method, is that a substrate comprising phenyl phosphate is hydrolyzed to liberate phenol, and the liberated phenol is oxidatively condensed with 4-aminoantipyrine in the presence of potassium ferricyanate to form red-colored quinone which is colorimetrically measured. A modified Kind-King method is that a borate buffer is used for stabilizing the coloring. Furthermore, the method using an alkaline salt of an aromatic sulfonehalogenamide such as Chloramine T etc. in place of potassium ferricyanide (Jap. Pat. Unexam. Publ. No. 52-155597) or using hydrogen peroxideperoxidase has also been proposed. In these methods, potassium ferricyanate is a cyanide compound which causes polution, and they are not advantageous for rate assay; and moreover, the hydrogen peroxide is unstable.
Another method is known, namely, the Bessey-Lowry method or Huggins-Talalay method, in which a substrate comprising p-nitrophenyl phosphate or phenylphthalein phosphate is reacted with a sample containing phosphomonoesterase, and the liberated p-nitrophenol or phenolphthalein is colorimetrically measured under alkaline conditions. But this method has disadvantages due to being affected by bilirubin and hemoglobin in the blood.
Likewise, a further method, in which naphthol liberated from a substrate α-naphthyl phosphate is measured at 340 nm, has disadvantages such as the effect of contaminants in the sample and the carcinogenicity of α-naphthol.
In the present invention, there is used a synthetic substrate for assaying phosphate, of the formula ##STR7## wherein one of R"'1 and R"'2 is ##STR8## and the other is hydrogen, R20 --O-- is HO-- or a substituted or unsubstituted glycerol residue, and R3, R4, R5 and R6 have the same meanings as hereinbefore.
In case the group R20 --O-- is an HO-- group, phenol compound [I] is liberated from the said synthetic substrate by the enzymatic action of the phosphomonoesterase in the sample, and the phenol compound [I] is colored with a corresponding coupler and oxidase to measure phosphomonoesterase activity.
Examples of synthetic substrates [VII] can be compounds bound with phenol compound [I] and a mono- or diglyceride phosphate or phosphoric acid, and glycerophosphate or a fatty acid ester substituent thereof. Examples of phenol compound [I] are mentioned hereinbefore. Compound [VII] can be synthesized by any conventional synthetic method using phenol compound [I] and phosphoric acid, or glycerophosphate or a fatty acid ester substituent thereof, or a commercially available reagent can also be used. Enzymatic activity can be assayed in a suitable buffer at 37° C. by contacting a sample containing phosphomonoesterase with a synthetic substrate, liberating the phenol compound [I] and measuring the same by a method as set forth hereinbefore.
As enzymes in phosphodiesterase can be mentioned phospholipase C (EC: 3.1.4.4) and phospholipase D (EC: 3.1.4.4). The synthetic substrate therefor is a compound [VII] wherein R20 --O-- is a substituted or unsubstituted glycerol residue. Examples of substituted glycerol residue are mono- and di-substituted fatty acid esters of glycerol. These synthetic substrates can also be used in the same way as in phosphomonoesterase. Phenol compound [I] is rapidly liberated in the case of phospholipase D; however, in the case of phospholipase C, it can be liberated when phosphatase is used jointly with phospholipase C.
(4) Esterase and lipase:
Esterase is an enzyme which hydrolyzes esters of fatty acids and alcohols, or synthesizes the same. An enzyme which hydrolyzes esters of lower fatty acids and monohydric alcohols is called esterase in its narrow meaning; and an enzyme which hydrolyzes fatty acid to three molecules of an ester of a higher fatty acid and the trihydric alcohol glycerol, is called lipase.
Examples of such enzymes are lipase in the pancreatic juice or caster oil, and esterase in the liver, stomach or serum. Lipase is known as an important enzyme for the diagnosis of pancreatitis in clinical biochemistry.
Hitherto-known assay methods of esterase and lipase are that a fatty acid ester is used as the substrate and enzymatically liberated fatty acid is measured by titration. This method has disadvantages, for example resulting from the high value in titration, and complex operation, and is unsuitable for the assay of many samples. Hence a simple colorimetric assay method has been desired.
A colorimetric assay using synthetic substrate p-nitro phenol acetate, p-nitrophenol laurylate or p-nitrophenol palmitate is one in which enzymatically-liberated p-nitrophenol is measured. This method has disadvantages because of the yellow color of the medium, which is affected by pigment (jaundice serum or hemolysate) in the specimen.
Another method using synthetic substrates, for example fatty acid esters of phenol, α-naphthol or β-naphthol such as phenol laurylate, β-naphthol laurylate or α-naphthyl palmitate, and measuring enzymatically liberated phenol, α- or β-naphthol, is known. Phenol is measured by the colorimetric method of Folin-Ciocalteau. But this method is quite complex and consumes much time and so is almost never used.
A further method is known, in which α-naphthol is reacted with Fast Violet B under alkaline conditions and the thus-formed red color of the diazonium salt is changed to colorless by 2% Triton X-100 solution and is colorimetrically measured at 520 nm. β-naphthol is bound with tetrazo-orthoanisidine to form a red colored insoluble pigment which is extracted with ethyl acetate to measure the same colorimetrically. These methods are, however, complex methods, and are dangerous due to the carcinogenicity of the naphthol.
The present assay method is one in which an ester compound of a fatty acid and a phenol compound [I] is used as the synthetic substrate. The said substrate has the formula ##STR9## wherein one of R""1 and R""2 is R21 --CO--O-- and the other is hydrogen in which R21 CO-- is a fatty acid residue, and R3, R4, R5 and R6 have the same meanings hereinbefore. The said synthetic substrate is hydrolyzed by esterase or lipase in the sample to liberate phenol compound [I], which is oxidatively condensed with a coupler by oxidase. The method is preferred for automatic analysis during rate assay and without affecting the contaminant in the serum due to measuring at long wavelength at 500-750 nm. The synthetic substrate can be synthesized by any conventional method or can be obtained commercially.
Examples of fatty acids are acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecylic acid, lauric acid, tridecanic acid, myristic acid, pentadecanoic acid and palmitic acid. Conventional synthesis methods can be used.
In an assay, it is preferable that a buffer solution be used. The amount of the synthetic substrate depends upon the amount of the sample, the enzymatic activity and the reaction time and is generally 0.1-20 mM/lit. and 0.01-5 ml. The enzymatic reaction is carried out at approximately 37° C. for a sufficient time to liberate amino compound [I] or phenol compound [I], usually more than one minute.
Amino compound [I] or phenol compound [I] can be measured by the method hereinbefore described. The enzymatic reaction for liberating the compound [I] from the substrate, and the measurement for the compound [I], can be performed either separately or preferably in one step by adding previously the necessary reagents and enzyme.
Furthermore, consumed oxygen can be measured by an oxygen electrode, and automatic rate assay or other colorimetry can be used.
The reagents and oxidase used in the enzymatic assay can be in liquid form, immobilized form or can be layered on a film or filter paper. Non-ionic surface active agents for solubilization and increasing the hydrophilic nature of the synthetic substrate and other stabilizers for oxidase can optionally be added.
In the accompany drawings:
FIG. 1 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, ASOD and 1-naphthol-2-sulfonate (solid line);
FIG. 2 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, ASOD and phenol (solid line);
FIG. 3 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, laccase and 1-naphthol-2-sulfonate (solid line);
FIG. 4 is the absorption curve of pigment using 2,6-dibromo-4-aminophenol, laccase and 2,5-dimethylphenol (solid line);
FIGS. 5 through 52 show the absorption curves (solid line) of pigments indicated in each numbered figure according to the following abbreviations:
Abbreviations used hereinbelow:
2,6-dibromo-4-aminophenol: 2,6-DBAP
N,N-diethyl-p-phenylenediamine: N,N-DEPD
N,N-dimethyl-p-phenylenediamine: N,N-DMPD; thus:
FIG. 5: 2,6-DBAP, laccase and phenol;
FIG. 6: N,N-DEPD, ASOD and phenol;
FIG. 7: N,N-DMPD, ASOD and phenol;
FIG. 8: 2,6-DBAP, ASOD and o-methylaniline;
FIG. 9: 2,6-DBAP, ASOD and m-methylaniline;
FIG. 10: 2,6-DBAP, ASOD and 4-chloro-1-naphthol;
FIG. 11: 2,6-DBAP, ASOD and Cleve's acid;
FIG. 12: 2,6-DBAP, ASOD and 1-hydroxy-2-naphthoic acid;
FIG. 13: N,N-DEPD, laccase and 1-naphthol-2-sulfonate;
FIG. 14: 2,6-DBAP, ASOD and o-chlorophenol;
FIG. 15: 2,6-DBAP, ASOD and m-aminophenol;
FIG. 16: 2,6-DBAP, ASOD and m-phenylenediamine;
FIG. 17: 2,6-DBAP, ASOD and 2,6-dibromophenol;
FIG. 18: 2,6-DBAP, ASOD and 2,6-dimethoxyphenol;
FIG. 19: 2,6-DBAP, ASOD and 3,5-dimethylphenol;
FIG. 20: 2,6-DBAP, ASOD and 2,6-dimethylphenol;
FIG. 21: 2,6-DBAP, ASOD and 2,4-dimethylphenol;
FIG. 22: 2,6-DBAP, ASOD and 2,3-dimethylphenol;
FIG. 23: 2,6-DBAP, ASOD and 2,5-dimethylphenol;
FIG. 24: 2,6-DBAP, ASOD and anthranilic acid;
FIG. 25: 2,6-DBAP, ASOD and N,N-dimethylaniline;
FIG. 26: 2,6-DBAP, ASOD and aniline;
FIG. 27: 2,6-DBAP, ASOD and m-chloroaniline;
FIG. 28: 2,6-DBAP, ASOD and o-aminophenol;
FIG. 29: N,N-DEPD, ASOD and o-chlorophenol;
FIG. 30: N,N-DEPD, ASOD and m-phenylenediamine;
FIG. 31: N,N-DEPD, ASOD and o-methylaniline;
FIG. 32: N,N-DEPD, ASOD and m-methylaniline;
FIG. 33: N,N-DEPD, ASOD and Cleve's acid;
FIG. 34: N,N-DEPD, ASOD and 1-naphthol-2-sulfonate;
FIG. 35: N,N-DEPD, ASOD and 2,6-dibromophenol;
FIG. 36: N,N-DEPD, ASOD and 2,6-dimethoxyphenol;
FIG. 37: N,N-DEPD, ASOD and 2,6-dimethylphenol;
FIG. 38: N,N-DEPD, ASOD and 2,5-dimethylphenol;
FIG. 39: N,N-DEPD, ASOD and N,N-dimethylaniline;
FIG. 40: N,N-DEPD, ASOD and aniline;
FIG. 41: N,N-DMPD, ASOD and o-chlorophenol;
FIG. 42: N,N-DMPD, ASOD and 2,6-dibromophenol;
FIG. 43: N,N-DMPD, ASOD and anthranilic acid;
FIG. 44: N,N-DMPD, ASOD and aniline;
FIG. 45: N,N-DMPD, ASOD and α-naphthol;
FIG. 46: N,N-DMPD, ASOD and 4-chloro-1-naphthol;
FIG. 47: N,N-DMPD, ASOD and 1-naphthol-2-sulfonate;
FIG. 48: N,N-DMPD, ASOD and m-phenylenediamine;
FIG. 49: N,N-DMPD, ASOD and o-methylaniline;
FIG. 50: N,N-DMPD, ASOD and m-methylaniline;
FIG. 51: 2,6-DBAP, ASOD and m-bromoaniline;
FIG. 52: 2,6-DBAP, tyrosinase and N,N-ethyl-hydroxyethylanilin
FIG. 53 is the standard curve of 2,6-DBAP using 1-naphthol-2-sulfonate and ASOD:
FIG. 54 is the standard curve of N,N-DEPD using phenol and ASOD;
FIG. 55 is the standard curve of phenol using N,N-diethyl-p-phenylenediamine and ASOD;
FIG. 56 is the standard curve of 2,6-DBAP using 2,5-dimethylphenol and ASOD;
FIG. 57 shows the changes in the absorption curve of pigment at 2-minute intervals during the reaction during α-glucosidase assay using phenol-α-glucoside and ASOD;
FIG. 58 shows the changes in the absorption curve of pigment at 5-minute intervals during the reaction during AlP assay using phenylphosphate and ASOD;
FIG. 59 shows the changes in the absorption curve of pigment at 2-minute intervals during the reaction during esterase assay using phenyl acetate and ASOD;
FIG. 60 is a graph of oxygen consumption ratio versus reaction time using 2,6-DBAP, 2,5-dimethylphenol and ASOD; and
FIG. 61 is a graph of oxygen consumption ratio versus reaction time using 2,6-DBAP, 2,5-dimethylphenol and laccase.
The following examples illustrate the conditions, the compound [I], the uses, etc. of the present invention, but are not to be construed as limiting.
Colorimetry using 2,6-dibromo-4-aminophenol, ascorbate oxidase (hereinafter called ASOD) and 1-naphthol-2-sulfonate:
2,6-dibromo-4-aminophenol hydrochloride was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.5 mM solution (solution A). 1-Naphthol-2-sulfonate was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.5 mM solution (solution B). ASOD (100 μl, 130 U) obtained from Sechium edule (Jap. Unexam. Pat. Publ. No. 56-88793) was added to a mixture of solution A (1.0 ml) and solution B (1.0 ml), and the mixture was incubated at 37° C. for 10 mins. The absorption wavelength of pigment formed is shown in FIG. 1 (solid line). A 0.1M phosphate buffer (pH 7.0) was used in place of solution B as a control. The results are shown in FIG. 1 (dotted line). The specific absorption maximum was found at 630 nm and thus 2,6-dibromo-4-aminophenol can be quantitatively measured.
The standard curve for 2,6-dibromo-4-aminophenol was prepared by incubating various concentrations of 2,6-dibromo-4-aminophenol (2 ml), 1-naphthol-2-sulfonate (0.5 mM, 1 ml) and ASOD (100 μl, 103 U) at 37° C. for 10 mins., and measuring at 630 nm (FIG. 53).
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by phenol (10 mM), but the other operations were performed in the same way.
The absorption curve of the pigment formed is shown in FIG. 2 (solid line). The absorption curve using a 0.1M phosphate buffer (pH 7.0) in place of phenol is shown in FIG. 2 (dotted line). 2,6-Dibromo-4-aminophenol can be measured by using ASOD and phenol at 610 nm.
Next, the 2,6-dibromo-4-aminophenol solution is replaced by 0.1M phosphate buffer (pH 7.0) to measure the absorption [FIG. 2 (-- --)].
As shown hereinabove, 2,6-dibromo-4-aminophenol or phenol can be quantitatively determined by the present method.
Colorimetry using 2,6-dibromo-4-aminophenol, laccase and 1-naphthol-2-sulfonate
2,6-Dibromo-4-aminophenol hydrochloride was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.5 mM solution (solution A). Potassium 1-naphthol-2-sulfonate was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.5 mM solution (solution B).
Laccase (100 μl, 80 U) obtained from Polyporus versicolor was added to a mixture of solutions A (1.0 ml) and B (1.0 ml) and the resulting mixture was incubated at 37° C. for 24 mins.
The absorption curve of the generated pigment is shown in FIG. 3 (solid line). As a control, potassium 1-naphthol-2-sulfonate was replaced by 0.1M phosphate buffer (pH 7.0). (FIG. 3, dotted line).
2,6-Dibromo-4-aminophenol can be quantitatively measured at 630 nm using laccase and potassium 1-naphthol-2-sulfonate.
In Example 3, potassium 1-naphthol-2-sulfonate was replaced by 2,5-dimethylphenol (10 mM).
The absorption curve of the generated pigment is shown in FIG. 4 (solid line). Also, results when 2,5-dimethylphenol is replaced by 0.1M phosphate buffer (pH 7.0) are shown in FIG. 4 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed by using laccase and 2,5-dimethylphenol.
The above laccase was replaced by tyrosinase (50 μl, 100 U) to obtain an absorption curve similar to FIG. 4 (specific absorption wavelength 585 nm, ΔOD585nm =0.8).
1 mM 2,6-dibromo-4-aminophenol and 10 mM 2,5-dimethylphenol in a 0.1M phosphate buffer (pH 7.0, 1 ml) was added to the incubation cell assembled with an oxygen electrode and preincubated at 37° C. ASOD solution (100 μl, 250 U) was added thereto and the mixture was incubated at 37° C. The electrochemical changes were measured with an oxygen electrode starting from zero time, that is, the time of ASOD addition, to measure the oxygen consumption ratio. The results are shown in FIG. 60.
ASOD hereinabove was replaced by laccase (100 μl, 200 U). The oxygen consumption ratio is shown in FIG. 61.
In Example 3, potassium 1-naphthol-2-sulfonate was replaced by phenol (10 mM).
The absorption curve of the generated pigment is shown in FIG. 5 (solid line). Phenol was replaced by a 0.1M phosphate buffer (pH 7.0) (FIG. 5, dotted line).
As shown by the above, phenol or 2,6-dibromo-4-aminophenol can be assayed at 600 nm.
N,N-diethyl-p-phenylenediamine-dihydrochloride was dissolved in 0.1M phosphate buffer (pH 7.0) to prepare a 1 mM solution (solution A). Phenol was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 10 mM solution (solution B). ASOD (100 μl, 130 U) was added to the mixture of solution A (1.0 ml) and solution B (1.0 ml) and the mixture was incubated at 37° C. for 20 mins. The absorption curve of the generated pigment is shown in FIG. 6 (solid line). The same reaction, but in which the phenol solution was replaced by a 0.1M phosphate buffer (pH 7.0), was carried out. The results are shown in FIG. 6 (dotted line). As shown by the above, N,N-diethyl-p-phenylenediamine or phenol can be assayed at 670 nm.
The standard curve of the above can be prepared as follows:
Various concentrations of N,N-diethyl-p-phenylenediamine solution (2 ml), phenol (10 mM, 1.0 ml) and ASOD (100 μl, 130 U) were incubated at 37° C. for 10 mins. and colorimetrically measured at 670 nm to prepare the standard curve of N,N-diethyl-p-phenylenediamine (FIG. 54).
Various concentrations of phenol (1 ml), N,N-diethyl-p-phenylenediamine (1 mM, 2 ml) and ASOD (100 μl, 130 U) were incubated at 37° C. for 10 mins. and colorimetrically measured at 670 nm to prepare the standard curve of phenol (FIG. 55).
In Example 6, N,N-diethyl-p-phenylenediamine dihydrochloride was replaced by N,N-dimethyl-p-phenylenediamine dihydrochloride and the mixture was incubated for 30 mins.
The absorption curve of the generated pigment is shown in FIG. 7 (solid line). Also, the phenol solution was replaced by a 0.1M phosphate buffer (pH 7.0) (FIG. 7, dotted line).
As shown by the above, N,N-dimethyl-p-phenylene diamine and phenol can be assayed at 655 nm.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by o-methylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 8 (solid line). Also a test in which o-methylaniline was replaced by 0.1M phosphate buffer (pH 7.0) is shown in FIG. 8 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 670 nm by using ASOD and o-methylaniline.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by m-methylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 9 (solid line). Also, a test conducted in which m-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0). The results are shown in FIG. 9 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 670 nm by using ASOD and m-methylaniline.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 4-chloro-1-naphthol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 10 (solid line). Also, the results when 4-chloro-1-naphthol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 10 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 580 nm by using ASOD and 4-chloro-1-naphthol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by Cleve's acid (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 11 (solid line). Also, the results when Cleve's acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 11 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 560 nm by using ASOD and Cleve's acid.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 1-hydroxy-2-naphthoic acid.
The absorption curve of the generated pigment is shown in FIG. 12 (solid line). Also, the results when 1-hydroxy-2-naphthoic acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 12 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 590 nm by using ASOD and 1-hydroxy-2-naphthoic acid.
In Example 3, 2,6-diethyl-p-phenylenediamine.2HCl was replaced by N,N-diethyl-p-phenylenediamine.2HCl (1 mM).
The absorption curve of the generated pigment is shown in FIG. 13 (solid line). Also, the results when potassium 1-naphthol-2-sulfonate was replaced by 0.1M phosphate buffer (pH 7.0) are shown in FIG. 13 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 660 nm by using laccase and potassium 1-naphthol-2-sulfonate.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by o-chlorophenol (0.1 mM).
The absorption curve of the generated pigment is shown in FIG. 14 (solid line). Also, the results when o-chlorophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 14 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 650 nm by using ASOD and o-chlorophenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by m-aminophenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 15 (solid line). Also, the results when m-aminophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 15 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 565 nm by using ASOD and m-aminophenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by m-phenylenediamine (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 16 (solid line). Also, the results when m-phenylenediamine was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 16 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 565 nm by using ASOD and m-phenylenediamine.
The absorption curve of the results when ASOD, m-phenylenediamine and phosphate buffer are used, is also shown in FIG. 16 (-- --).
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,6-dibromophenol:
The absorption curve of the generated pigment is shown in FIG. 17 (solid line). Also, the results when 2,6-dibromophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 17 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 670 nm by using ASOD and 2,6-dibromophenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,6-dimethoxyphenol (0.1 mM).
The absorption curve of the generated pigment is shown in FIG. 18 (solid line). Also, the results when 2,6-dimethoxyphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 18 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 580 nm by using ASOD and 2,6-dimethoxyphenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 3,5-dimethylphenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 19 (solid line). Also, the results when 3,5-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 19 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 620 nm by using ASOD and 3,5-dimethylphenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,6-dimethylphenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 20 (solid line). Also, the results when 2,6-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 20 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 580 nm by using ASOD and 2,6-dimethylphenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,4-dimethylphenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 21 (solid line). Also, the results when 2,4-dimethylphenol was replaced by 0.1M phosphate buffer (pH 7.0) are shown in FIG. 21 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 585 nm by using ASOD and 2,4-dimethylphenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,3-dimethylphenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 22 (solid line). Also, the results when 2,3-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 22 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 590 nm by using ASOD and 2,3-dimethylphenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,5-dimethylphenol (10 m).
The absorption curve of the generated pigment is shown in FIG. 23 (solid line). Also, the results when 2,5-dimethylphenol was replaced by 0.1M phosphate buffer (pH 7.0) are shown in FIG. 23 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 585 nm by using ASOD and 2,5-dimethylphenol.
Various concentrations of 2,6-dibromo-4-aminophenol (2 ml), 2,5-dimethylphenol (13.3 mM, 1 ml) and ASOD (100 μl, 130 U) are incubated at 37° C. for 10 mins., and colorimetrically measured at 585 nm to obtain the standard curve of 2,6-dibromo-4-aminophenol (FIG. 56).
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by anthranilic acid (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 24 (solid line). Also, the results when anthranilic acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 24 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 640 nm by using ASOD and anthranilic acid.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by N,N-dimethylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 25 (solid line). Also, the results when N,N-dimethylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 25 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 700 nm by using ASOD and N,N-dimethylaniline.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by aniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 26 (solid line). Also, the results when aniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 26 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 630 nm by using ASOD and aniline.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by m-chloroaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 27 (solid line). Also, the results when m-chloroaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 27 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 635 nm by using ASOD and m-chloroaniline.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by o-aminophenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 28 (solid line). Also, the results when o-aminophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 28 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 580 nm by using ASOD and o-aminophenol.
The absorption curve of the reaction was ASOD and o-aminophenol is also shown in FIG. 28 (-- --).
In Example 6, phenol was replaced by o-chlorophenol (0.1 mM).
The absorption curve of the generated pigment is shown in FIG. 29 (solid line). Also, the results when o-chlorophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 29 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 690 nm by using ASOD and o-chlorophenol.
In Example 6, phenol was replaced by m-phenylenediamine (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 30 (solid line). Also, the results when m-phenylenediamine was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 30 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 665 nm by using ASOD and m-phenylenediamine.
In Example 6, phenol was replaced by o-methylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 31 (solid line). Also, the results when o-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 31 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 700 nm by using ASOD and o-methylaniline.
In Example 6, phenol was replaced by m-methylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 32 (solid line). Also the results when m-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 32 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 710 nm by using ASOD and m-methylaniline.
In Example 6, phenol was replaced by Cleve's acid (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 33 (solid line). Also, the results when Cleve's acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 33 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 755 nm by using ASOD and Cleve's acid.
In Example 6, phenol was replaced by potassium 1-naphthol-2-sulfonate (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 34 (solid line). Also, the results when potassium 1-naphthol-2-sulfonate was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 34 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 655 nm by using ASOD and potassium 1-naphthol-2-sulfonate.
In Example 6, phenol was replaced by 2,6-dibromophenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 35 (solid line). Also, the results when 2,6-dibromophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 35 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 700 nm by using ASOD and 2,6-dibromophenol.
In Example 6, phenol was replaced by 2,6-dimethoxyphenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 26 (solid line). Also, the results when 2,6-dimethoxyphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 36 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 630 nm by using ASOD and 2,6-dimethoxyphenol.
The absorption curve of the reaction with ASOD and 2,6-dimethoxyphenol is also shown in FIG. 36 (-- --).
In Example 6, phenol was replaced by 2,6-dimethylphenol (10 mM).
The absorption curve of the generated pigment is shown in FIG. 37 (solid line). Also, the results when 2,6-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 37 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 630 nm by using ASOD and 2,6-dimethylphenol.
In Example 6, phenol was replaced by 2,5-dimethylphenol (10 mM).
The absorption curve of the generated pigment is shown in FIG. 38 (solid line). Also, the results when 2,5-dimethylphenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 38 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 640 nm by using ASOD and 2,5-dimethylphenol.
In Example 6, phenol was replaced by N,N-dimethylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 39 (solid line). Also, the results when N,N-dimethylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 39 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 730 nm by using ASOD and N,N-dimethylaniline.
In Example 6, phenol was replaced by aniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 40 (solid line). Also, the results when aniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 40 (dotted line).
As illustrated hereinabove, N,N-diethyl-p-phenylenediamine can be assayed at 690 nm by using ASOD and aniline.
The absorption curve of the reaction of ASOD and aniline is also shown in FIG. 40 (-- --).
In Example 7, phenol was replaced by o-chlorophenol (0.1 mM).
The absorption curve of the generated pigment is shown in FIG. 41 (solid line). Also, the results when o-chlorophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 41 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 680 nm by using ASOD and o-chlorophenol.
In Example 7, phenol was replaced by 2,6-dibromophenol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 42 (solid line). Also, the results when 2,6-dibromophenol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 42 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 695 nm by using ASOD and 2,6-dibromophenol.
In Example 7, phenol was replaced by anthranilic acid (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 43 (solid line). Also, the results when anthranilic acid was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 43 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 680 nm by using ASOD and anthranilic acid.
In Example 7, phenol was replaced by aniline.
The absorption curve of the generated pigment is shown in FIG. 44 (solid line). Also, the results in which aniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 44 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 690 nm by using ASOD and aniline.
In Example 7, phenol was replaced by 2-naphthol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 45 (solid line). Also, the results when 2-naphthol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 45 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 630 nm by using ASOD and 2-naphthol.
In Example 7, phenol was replaced by 4-chloro-1-naphthol (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 46 (solid line). Also, the results when 4-chloro-1-naphthol was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 46 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 640 nm by using ASOD and 4-chloro-1-naphthol.
In Example 7, phenol was replaced by potassium 1-naphthol-2-sulfonate (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 47 (solid line). Also, the results when potassium 1-naphthol-2-sulfonate was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 47 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 650 nm by using ASOD and potassium 1-naphthol-2-sulfonate.
In Example 7, phenol was replaced by m-phenylenediamine (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 48 (solid line). Also, the results when m-phenylenediamine was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 48 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 650 nm by using ASOD and m-phenylenediamine.
In Example 7, phenol was replaced by o-methylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 49 (solid line). Also, the results when o-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 49 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 695 nm by using ASOD and o-methylaniline.
In Example 7, phenol was replaced by m-methylaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 50 (solid line). Also, the results when m-methylaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 50 (dotted line).
As illustrated hereinabove, N,N-dimethyl-p-phenylenediamine can be assayed at 705 nm by using ASOD and m-methylaniline.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by m-bromoaniline (0.5 mM).
The absorption curve of the generated pigment is shown in FIG. 51 (solid line). Also, the results when m-bromoaniline was replaced by a 0.1M phosphate buffer (pH 7.0) are shown in FIG. 51 (dotted line).
As illustrated hereinabove, 2,6-dibromo-4-aminophenol can be assayed at 635 nm by using ASOD and m-bromoaniline.
Colorimetry Using 2,6-dibromo-4-aminophenol, tyrosinase and N,N-ethyl-hydroxyethylaniline
2,6-dibromo-4-aminophenol hydrochloride was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 0.05M solution (solution A). N,N-ethyl-hydroxyethylaniline was dissolved in a 0.1M phosphate buffer (pH 7.0) to prepare a 5 mM solution (solution B). A tyrosinase solution (50 μl, 100 U) was added to a mixture of solution A (1.0 ml) and B (1.0 ml), and the mixture was incubated at 37° C. for 10 mins.
The absorption curve of the generated pigment is shown in FIG. 52, in which the specific absorption is at 705 nm, and 2,6-dibromo-4-aminophenol can be assayed at 705 nm.
Pigments showing the same specific absorption was obtained using ASOD and laccase, respectively, in place of tyrosinase.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by m-chlorophenol (0.1 mM).
The absorption maximum of the generated pigment was at approximately 650 nm. As a result, 2,6-dibromo-p-aminophenol can be assayed at 650 nm using ASOD and m-chlorophenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by o-chloroaniline (0.5 mM).
The absorption maximum of the generated pigment was at approximately 630 nm. As a result, 2,6-dibromo-p-aminophenol can be assayed at 630 nm using ASOD and o-chloroaniline.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by p-chlorophenol (1 mM).
The absorption maximum of the generated pigment was at approximately 620 nm. As a result, 2,6-dibromo-p-aminophenol can be assayed at 620 nm using ASOD and p-chlorophenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by p-bromophenol (1 mM).
The absorption maximum of the generated pigment was at approximately 600 nm. As a result, 2,6-dibromo-p-aminophenol can be assayed at 600 nm using ASOD and p-bromophenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,4-dichlorophenol (0.1 mM).
The absorption maximum of the generated pigment was at approximately 660 nm. As a result, 2,6-dibromo-p-aminophenol can be assayed at 660 nm using ASOD and 2,4-dichlorophenol.
In Example 1, potassium 1-naphthol-2-sulfonate was replaced by 2,4-dibromophenol (1 mM).
The absorption maximum of the generated pigment was at approximately 660 nm. As a result, 2,6-dibromo-p-aminophenol can be assayed at 660 nm using ASOD and 2,4-dibromophenol.
In Example 6, phenol was replaced by α-naphthol (0.5 mM).
The absorption maximum of the generated pigment was at approximately 620 nm. As a result, N,N-diethyl-p-phenylenediamine can be assayed at 620 nm using ASOD and α-naphthol.
In Example 6, phenol was replaced by m-chlorophenol (0.5 mM).
The absorption maximum of the generated pigment was at approximately 695 nm. As a result, N,N-diethyl-p-phenylenediamine can be assayed at 695 nm using ASOD and m-chlorophenol.
In Example 6, phenol was replaced by 2,3-dimethylphenol (10 mM).
The absorption maximum of the generated pigment was at approximately 625 nm. As a result, N,N-diethyl-p-phenylenediamine can be assayed at 625 nm using ASOD and 2,3-dimethylphenol.
In Example 6, phenol was replaced by anthranilic acid (0.5 mM).
The absorption maximum of the generated pigment was at approximately 680 nm. As a result, N,N-dimethyl-p-phenylenediamine can be assayed at 680 nm using ASOD and anthranilic acid.
In Example 6, phenol was replaced by 2,4-dimethylphenol (10 mM).
The absorption maximum of the generated pigment was at approximately 630 nm. As a result, N,N-diethyl-p-phenylenediamine can be assayed at 630 nm using ASOD and 2,4-dimethylphenol.
In Example 7, phenol was replaced by N,N-dimethylaniline (0.5 mM).
The absorption maximum of the generated pigment was at approximately 725 nm. As a result, N,N-dimethyl-p-phenylenediamine can be assayed at 725 nm using ASOD and N,N-dimethylaniline.
S-Benzyl-L-cysteinyl-p-dimethylaminoanilide (100 mg), obtained by a conventional dehydration condensation of N,N-dimethyl-p-phenylenediamine.2 HCl, N-benzyloxycarbonyl-S-benzyl-L-cysteine and dicyclohexylcarbodiimide, followed by removing the protective group, was dissolved in a mixture of dioxane (3 ml) and 0.16N-HCl, and mixed with 0.1M triethanolaminecitrate buffer (pH 7.4, 100 ml) containing 1.25% Tween 80 (surface active agent) to prepare a synthetic substrate solution. The substrate solution (2 ml), p-xylenol (5 mM, 0.1 ml) and laccase (2000 U/ml, 100 μl) were mixed in a cell for colorimetry and the mixture was preincubated at 37° C. Pregnant serum containing CPA (238 mU/ml) was admixed therein to start the reaction. The absorption ratio after 30 mins. measured at 600 nm was O.D.600 =0.18. As a result, CAP assay can desirably be performed by this method.
In Example 65, N,N-dimethyl-p-phenylenediamine.2HCl was replaced by 3,5-dibromo-4-hydroxyaniline to prepare S-benzyl-L-cysteine-3,5-dibromo-4-hydroxyanilide, and the remaining procedure was conducted the same as in Example 65.
The absorption ratio after 30 mins. was measured at 585 nm to obtain O.D.585 =0.195. As a result, CAP assay can desirably be performed by this method.
In Example 66, laccase was replaced by ASOD (1320 U/ml) and the remaining procedure was conducted as in that example. O.D.585 =0.175 was obtained. CAP assay can desirably be performed by this method.
In Example 65, N,N-dimethyl-p-phenylenediamine.2HCl was replaced by N,N-diethyl-p-phenylenediamine to obtain S-benzyl-L-crysteinyl-p-diethylaminoanilide, and p-xylenol (5 mM) was replaced by 1-naphthol-2-sulfonate (2 mM). The absorbency was measured at 655 nm to obtain O.D.655 =0.205. CAP assay can desirably be performed by this method.
p-Dimethylaminoaniline.2HCl and N-benzyloxycarbonyl-L-tyrosine were condensed with dicyclohexylcarbodiimide, and the protective group was removed by palladium-carbon catalyst, then the resulting compound was reacted with benzoylchloride to obtain as a synthetic substrate N-benzoyl-L-tyrosinyl-p-dimethylaminoanilide. The synthetic substrate (30 mg) was dissolved in acetone (5 ml) to prepare an original substrate solution. 0.1M Tris-HCl buffer (pH 7.8, 100 ml) (containing 5 mM calcium chloride and 1% Tween 80) was added to the original solution to prepare a substrate solution.
The substrate solution (2 ml), p-xylenol (15 mM, 0.1 ml) and laccase (2000 U/ml, 100 μl) were mixed well in a colorimetric cell, and the mixture was preincubated at a constant temperature of 37° C. α-Chymotrypsin (3 mg/ml, 50 μl) was added thereto to start the reaction. The absorbency after 30 mins. was measured at 600 nm to obtain O.D.600 =0.48. As a result, α-chymotrypsin can desirably be assayed by this method.
N-benzyloxycarbonyl-L-tryptophan and N,N-diethyl-p-phenylenediamine were condensed with dicyclohexylcarbodiimide under ice cooling, and the protective group was removed by palladium-carbon catalyst, then the product was acetylated with acetic anhydride to obtain N-acetyl-L-tryptophan-p-diethylaminoanilide. This compound (30 mg) was dissolved in acetone (5 ml) to prepare an original substrate solution. 0.1M Tris-HCl buffer (pH 7.8, 100 ml, containing 5 mM calcium chloride and 1% Tween 80) was added to prepare the synthetic substrate solution.
The synthetic substrate solution (2 ml), 1-naphthol-2-sulfonate (2 mM, 0.1 ml) and laccase (2000 U/ml), 100 μl) were mixed well in a colorimetric cell and the mixture was preincubated at a constant temperature of 37° C. Trypsin (50 μl) was added thereto to start the reaction. The absorbency after 30 mins. was measured at 655 nm to obtain O.D.655 =0.38. As a result, trypsin can desirably be assayed by this method.
In Example 69, p-dimethylaminoaniline 2HCl was replaced by p-diethylaminoaniline to obtain N-benzyl-L-tyrosinyl-p-diethylaminoanilide. This compound (30 mg) was dissolved in acetone (5 ml) to prepare an original substrate solution. The substrate solution was prepared the same way as in Example 69.
Then, in Example 69, p-xylenol (5 mM) was replaced by 1-naphthyl-2-sulfonate (2 mM) and the absorbency was measured at 655 nm to obtain O.D.655 =0.52. As a result, α-chymotrypsin can desirably be assayed by this method.
3,5-Dibromo-4-hydroxyaniline and N-benzyloxycarbonyl-L-tyrosine were condensed by a conventional dehydration condensation with dicyclohexylcarbodiimide and the protective group was removed by palladium-carbon catalyst, then the product was reacted with benzoylchloride to obtain a synthetic substrate comprising N-benzoyl-L-tyrosine-3,5-dibromo-4-hydroxyanilide. The synthetic substrate (30 mg) was dissolved in acetone (5 ml) to prepare the original substrate solution. 0.1M Trist-HCl buffer (pH 7.8, 100 m containing 5 mM calcium chloride and 1% Tween 80) was added thereto to prepare the substrate solution.
The substrate solution (2 ml), p-xylenol (5 mM, 0.1 ml) and laccase (2000 U/ml, 100 μl) were mixed well in a colorimetric cell and the mixture was preincubated at a constant temperature of 37° C. α-Chymotrypsin (3 mg/ml, 50 μl) was added to start the reaction. The absorbency after 39 mins. was measured at 585 nm (O.D.585 =0.465). As a result, α-chymotrypsin can desirably be measured by this method.
In Example 72, laccase was replaced by ASOD (1320 U/ml, 100 μl) to obtain the absorption ratio O.D.585 =0.452. As a result, α-chymotrypsin can desirably be measured by this method.
Phenyl-α-D-glucoside (Nakarai Chem. Co.) (0.24 mM) dissolved in a 0.1M phosphate buffer (pH 7.0, 2 ml), 2,6-dibromo-4-aminophenol (1 mM, 1 ml) and ASOD obtained from Sechium edule (1320 U/ml, 100 μl) were mixed in a colorimetric cell and preincubated to constant temperature at 30° C. α-Glucosidase (Toyobo Co., 3000 U/ml, 10 μl) was added thereto to start the reaction, and changes of absorption wavelength were recorded every 2 mins. The result are shown in FIG. 57. As a result, α-glucosidase activity can be assayed at 610 nm by reacting with liberated phenol from substrate phenyl-α-D-glucosidase, ASOD and a coupler.
A hydroxyl group in maltopentaose was conventionally acetylated with sodium acetate and acetic anhydride. The thus-obtained maltopentaose-β-heptadeca acetate was mixed with phenol and anhydrous zinc chloride to effect a coupling reaction. The obtained α- and β-phenylhexadeca acetylmaltopentaoside was deacetylated in a sodium methoxide solution in methanol. The phenyl hexadecamaltopentaoside thus obtained was dissolved in a 0.05M glycerophosphate buffer (pH 7.0) containing 2% α-cyclodextrin to prepare a 0.4% substrate solution. An enzyme solution (50 μl) containing α-glucosidase (500 U/ml) and β-glucosidase (100 U/ml), 2,6-dibromo-4-aminophenol (5 mM, 50 μl) and laccase (2000 U/ml, 100 μl) was thoroughly mixed in a colorimetric cell and the mixture was preincubated at 37° C. α-Amylase (Boehringer g.m.b.H., 5000 I.U./lit., 500 μl) was added to start the reaction. The absorption after 20 mins. was O.D.610 =0.412. As a result, a-amylase activity can desirably be measured by this method.
An α, β-mixture of o-chlorophenylmaltopentaoside was dissolved in a 0.05M glycerophosphate buffer (pH 7.0) containing 2% α-cyclodextrin to prepare a 0.4% substrate solution. The substrate solution (2 ml), an enzyme solution (50 μl) containing α-glucosidase (500 u/ml) and β-glucosidase (100 U/ml), 2,6-dibromo-4-aminophenol (5 mM, 50 μl) and laccase (2000 U/ml, 100 μl) were mixed thoroughly in a colorimetric cell and preincubated at 37° C. α-Amylase (Boehringer, 5000 I.U./lit., 500 μl) was added thereto to start the reaction. The absorbency after 20 mins. was measured at 650 nm to obtain O.D.650 =0.38. As a result, α-amylase activity can desirably be assayed by this method.
A hydroxyl group in maltopentaose is acetylated by a conventional method using sodium acetate and acetic anhydride. The obtained maltopentaose-α-heptadeca acetate, 2,6-dibromophenol and anhydrous zinc chloride were conventionally used to effect a coupling reaction to obtain α- and β-2,6-dibromophenyl hexadeca acetylmaltopentaoside. This product was deacetylated by sodium methoxide in methanol to obtain 2,6-dibromophenylhexadeca maltopentaoside which was dissolved in a 0.05M glycerophosphate buffer (pH 7.0) containing α-cyclodextrin 2% to prepare a 0.4% substrate solution.
The substrate solution (2 ml), an enzyme solution (50 μl) containing α-glucosidase (500 U/ml) and β-glucosidase (100 U/ml), 2,6-dibromo-4-aminophenol (5 mM, 50 μl) and laccase (2000 U/ml, 100 μl) were mixed thoroughly in a colorimetric cell and preincubated at a constant temperature of 37° C. α-Amylase (Boehringer, 5000 I.U./lit., 50 μl) was added thereto start the reaction. The absorbency after 20 mins. was O.D.670 =0.387. As a result, α-amylase can desirably be measured by this method.
In Example 77, laccase was replaced by ASOD (1310 U/ml) to obtain an absorbency of O.D.670 =0.378. As a result, α-amylase activity can desirably be assayed by this method.
Phenylphosphate .2Na (5 mM, 2 ml) dissolved in a 0.1M Tris-HCl buffer (pH 8.0), 2,6-dibromo-4-aminophenol (1 mM, 1 ml) and ASOD (1320 U/ml, 100 μl) obtained from Sechium edule were mixed thoroughly in a colorimetric cell and preincubated at 30° C. AlP (Boehringer, 400 U/0.17 ml, 10 μl) was added thereto to start the reaction, and the changes of absorbency were checked every 5 mins. The results are shown in FIG. 58. AlP activity can be assayed by reacting the liberated phenol from phenylphosphate, ASOD and a coupler.
2,6-dibromo phenylphosphate obtained by esterification of a phosphate and 2,6-dibromophenol were dissolved in a 0.1M Tris-HCl buffer (pH 8.0) to prepare a substrate solution (5 mM). This substrate solution (2 ml), 2,6-dibromo-4-aminophenol (1 mM, 1 ml) and laccase (2000 U/ml, 100 μl) were mixed thoroughly in a colorimetric cell and preincubated at 37° C. AlP (Boehringer, 400 U/0.17 ml, 10 μl) was added thereto to start the reaction. The absorbency after 30 mins. was O.D.670 =1.253. AlP can desirably be assayed by this method.
Phenyl acetate (Tokyo Kasei K.K., 5 mM, 1 ml) dissolved in a 0.1M phosphate buffer (pH 7.0), 2,6-dibromo-4-aminophenol (0.5 mM, 1 ml) and ASOD obtained from Sechium edule (60 U/ml, 20 μl) were mixed thoroughly in a colorimetric cell and preincubated at 30° C. Lipase (Toyo Jozo Co., 2545 U/ml, 100 μl) was added thereto to start the reaction and the changes of absorption every 2 mins. were measured (FIG. 59). As a result, lipase (esterase) can desirably be assayed by reacting the liberated phenol from substrate phenylacetate, ASOD and coupler.
Boc-Arg(NO2)-OH and N,N-diethylamino-p-phenylenediamine were condensed by a water soluble carbodiimide and the protective group removed to prepare H-Arg (NO2)-diethylaminoanilide. Boc-Leu-Gly-ester was de-esterified by an alkali to obtain Boc-Leu-Gly-OH. Both of these products were condensed in butanol by a water soluble carbodiimide to obtain Boc-Leu-Gly-Arg(NO2)-diethyl-aminoanilide, which was split at the --NO2 group by palladium catalytic reduction to prepare Boc-Leu-Gly-Arg-diethylaminoanilide. The product was dissolved in a 0.2M Tris-HCl buffer (pH 7.3) containing 0.005M CaCl2 to prepare a substrate solution (2.5 mM). The substrate solution (2 ml), 1-naphthol-2-sulfonate (2 mM, 1 ml) and laccase (2000 U/ml, 100 μl) were mixed thoroughly in a colorimetric cell and preincubated at 37° C. An endotoxin activation enzyme (50 μl) was added thereto to start the reaction. The absorbency at 655 nm was measured (O.D.655 =0.268). As a result, bacterial endotoxin can be assayed by this method. [Preparation of endotoxin activation enzyme]:
Blood lymphocytes (about 100 ml) were collected, carefully avoiding contamination, from Tachypleus tridentatus (about 2 kg weight) (Jap. Pat. Publ. No. 51-40131). Amoebocytes, separated by centrifugation, were washed with 3% aq. NaCl to obtain ameobocyte pellets. A buffer solution (Tris-HCl 0.05M; CaCl2 0.001M; NaCl 0.15M; pH 7.2) was added at a ratio of 1/10 v/v of the original blood lymphocytes, and the mixture was stirred thoroughly in a sterilized homogenizer and subjected to freeze-thawing and centrifugation at 50,000 rpm for 15 mins. to obtain the supernatant which was designated Amoebocyte lysate Tachypleus (ALT). This ALT was gel-filtered through Sephadex G-50 (Pharmacia Fine Chem. Co.) according to the method of Young et al. [N. S. Young et al., J. Clin. Invest., 51, 1790 (1972)] to obtain a fraction containing a precursor of amidase, which was treated by endotoxin prepared from Salmonella minesota R595 [M, Niwa et al. Jap. J. Med. Sci. Biol., 26, 20 (1973)] to obtain an endotoxin activation enzyme.
Claims (17)
- assay said compound..]. .[.2. An assay method according to claim 1, in which R1 is amino, or hydrogen if at least one of R2, R3, R4, R5 and R6 is amino, and R2, R3, R4, R5 and R6 have the same meanings as before, said coupler being a compound of the formula ##STR11## wherein R7 is hydroxyl, amino or substituted amino, and R8, R9, R10, R11 and R12 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or
- sulfo, or R11 and R12 together form a ring..]. .[.3. An assay method according to claim 1, in which R1 is hydroxyl, or hydrogen if at least one of R2, R3, R4, R5 and R6 is hydroxyl, and R2, R3, R4, R5 and R6 have the same meanings as before, said coupler being a compound of the formula ##STR12## wherein R13 is amino or substituted amino, and R14, R15, R16, R17 and R18 are hydrogen, halogen, lower alkyl, lower alkoxy, amino substituted amino, hydroxyl, carboxyl or sulfo, or R17
- and R18 together form a ring..]. .[.4. An assay method according to claim 1, wherein said oxidase is an oxidase for an aromatic ring compound having a hydroxyl or amino substituent..]. .[.5. An assay method according to claim 4, wherein said oxidase is ascorbate oxidase, laccase or tyrosinase..]. .[.6. An assay method according to claim 1, wherein said detectable change is the amount of consumed oxygen or generated pigment..]. .[.7. An assay method according to claim 6, and performing said measurement electrochemically..]. .[.8. An assay method according to
- claim 7, and performing said measurement by an oxygen electrode..]. .[.9. An assay method according to claim 6, and performing said measurement of the amount of generated pigment by a colorimetric assay at a specific absorption wavelength thereof..]. .[.10. An assay method according to claim 1, wherein said compound to be assayed is generated from a synthetic substrate by the action of a hydrolase..]. .[.11. An assay method according to claim 10, wherein said hydrolase is a peptidase or protease and the synthetic substrate is a compound of the formula ##STR13## wherein one of R'1 and R'2 is R19 CO--NH-- and the other is hydrogen, in which R19 CO-- is an amino acid residue or peptide residue, and R3, R4, R5 and R6 have the same meanings
- as before..]. .[.12. An assay method according to claim 10, wherein said hydrolase is glycosidase and the synthetic substrate is a compound of the formula ##STR14## wherein one of R"1 and R"2 is (S)n --O-- and the other is hydrogen, in which S is a monosaccharide unit and n is integer greater than 1, and R3, R4, R5 and R6 have the same meanings
- as before..]. .[.13. An assay method according to claim 10, wherein said hydrolase is a phosphatase and the synthetic substrate is a compound of the formula ##STR15## wherein one of R"'1 and R"'2 is ##STR16## and the other is hydrogen, in which R20 ##STR17## or a substituted or unsubstituted glycerol residue, and R3, R4,
- R5 and R6 have the same meanings as before..]. .[.14. An assay method according to claim 10, wherein said hydrolase is an esterase or lipase, and the synthetic substrate is a compound of the formula ##STR18## wherein one of R""1 and R""2 is R21 CO--O-- and the other is hydrogen, in which R21 CO-- is a fatty acid residue, and R3,
- R4, R5 and R6 have the same meanings as before..]. 15. A method for assaying a hydrolase, comprising the steps of: generating from a synthetic substrate by the action of said hydrolase a compound of the formula ##STR19## wherein R1 is hydroxyl or amino, or hydrogen if at least one of R2, R3, R4, R5 and R6 is hydroxyl or amino, and R2, R3, R4, R5 and R6 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxy, .[.carobxyl.]. .Iadd.carboxyl.Iaddend., or sulfo, or R5 and R6 together form a .Iadd.fused benzene .Iaddend.ring; establishing a reaction system containing .[.a.]. said compound and a coupler and an oxidase that consumes O2 and effects an enzymatic oxidative condensation of said compound and said coupler, simultaneously generating a pigment, without the formation of any H2 O2 ; measuring a detectable change in said reaction system to assay said compound; and relating the assay of said compound to said hydrolase consumed in generating said compound,
- thereby to assay said hydrolase. 16. An assay method according to claim 15, wherein the said hydrolase assay is an assay of .[.piptidase.].
- .Iadd.peptidase .Iaddend.or protease. 17. An assay method according to claim 15, wherein the said hydrolase assay is an assay of glycosidase.
- An assay method according to claim 15, wherein the said hydrolase
- assay is an assay of phosphatase. 19. An assay method according to claim 15, wherein the said hydrolase assay is an assay of esterase or lipase. .Iadd.20. An assay method according to claim 15, in which R1 is amino, or hydrogen if at least one of R2, R3, R4, R5 and R6 is amino, and R2, R3, R4, R5 and R6 have the same meanings as before, said coupler being a compound of the formula ##STR20##.Iaddend. wherein R7 is hydroxyl, amino or substituted amino, and R8, R9, R10, R11 and R12 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R11 and R12 together form a fused benzene ring.
- .Iadd.1. An assay method according to claim 15, in which R1 is hydroxyl, or hydrogen if at least one of R2, R3, R4, R5 and R6 is hydroxyl, and R2, R3, R4, R5 and R6 have the same meanings as before, said coupler being a compound of the formula ##STR21##.Iaddend. wherein R13 is amino or substituted amino, and R14, R15, R16, R17 and R18 are hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, hydroxyl, carboxyl or sulfo, or R17 and R18 together form a fused benzene ring.
- .Iadd.2. An assay method according to claim 15, wherein said oxidase is an oxidase for an aromatic ring compound having a hydroxyl or amino substituent. .Iaddend. .Iadd.23. An assay method according to claim 22, wherein said oxidase is ascorbate oxidase, lactase or tyrosinase. .Iaddend. .Iadd.24. An assay method according to claim 15, wherein said detectable change is the amount of consumed oxygen or generated pigment. .Iaddend. .Iadd.25. An assay method according to claim 24, and performing said measurement electrochemically. .Iaddend. .Iadd.26. An assay method according to claim 25, and performing said measurement by an oxygen electrode. .Iaddend. .Iadd.27. An assay method according to claim 24, and performing said measurement of the amount of generated pigment by a colorimetric assay at a specific absorption wavelength thereof. .Iaddend. .Iadd.28. An assay method according to claim 15, wherein said hydrolase is a peptidase or protease and the synthetic substrate is a compound of the formula ##STR22##.Iaddend. wherein one of R'1 and R'2 is R19 CO--NH-- and the other is hydrogen, in which R19 CO-- is an amino acid residue or peptide residue, and R3, R4, R5 and R6 have the same
- meanings as before. .Iadd.29. An assay method according to claim 15, wherein said hydrolase is glycosidase and the synthetic substrate is a compound of the formula ##STR23##.Iaddend. wherein one of R"1 and R"2 is (S)n --O-- and the other is hydrogen, in which S is a monosaccharide unit and n is integer greater than 1, and R3, R4, R5 and R6 have the same meanings as before, and wherein the linkages between the monosaccharide units and between the monosaccharide unit and the phenyl ring can be
- hydrolyzed by said glycosidase. .Iadd.30. An assay method according to claim 15, wherein said hydrolase is a phosphatase and the synthetic substrate is a compound of the formula ##STR24##.Iaddend. wherein one of R"'1 and R"'2 is ##STR25## and the other is hydrogen, in which R20 is ##STR26## or a substituted or unsubstituted glycerol residue, and R3, R4,
- R5 and R6 have the same meanings as before. .Iadd.31. An assay method according to claim 15, wherein said hydrolase is an esterase or lipase, and the synthetic substrate is a compound of the formula ##STR27##.Iaddend. wherein one of R""1 and R""2 is R21 CO--O-- and the other is hydrogen, in which R21 CO-- is a fatty acid residue, and R3, R4, R5 and R6 have the same meanings as before.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/203,071 USRE33635E (en) | 1982-10-01 | 1988-06-06 | Enzymatic assay method |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57173569A JPS5963198A (en) | 1982-10-01 | 1982-10-01 | Quantitative assay using enzyme |
| US07/203,071 USRE33635E (en) | 1982-10-01 | 1988-06-06 | Enzymatic assay method |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US06/538,680 Reissue US4681841A (en) | 1982-10-01 | 1983-10-03 | Enzymatic assay method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USRE33635E true USRE33635E (en) | 1991-07-09 |
Family
ID=26495497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/203,071 Expired - Lifetime USRE33635E (en) | 1982-10-01 | 1988-06-06 | Enzymatic assay method |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USRE33635E (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6624147B1 (en) * | 1999-09-28 | 2003-09-23 | Rijksuniversiteit Leiden | Inhibitors of prenylated pyrophosphate consuming enzymes |
| CN115992198A (en) * | 2022-11-14 | 2023-04-21 | 青岛科技大学 | Method for measuring activity of dextranase and application thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4177109A (en) * | 1977-05-30 | 1979-12-04 | Wako Pure Chemical Industries, Ltd. | γ-glutamyl-p-aminoanilide derivatives for measuring activity of γ-glutamyl transpeptidase |
| US4209459A (en) * | 1978-06-01 | 1980-06-24 | Nitto Boseki Co., Ltd. | Novel L-leucyl-4-hydroxyanilide derivatives |
| GB2103607A (en) * | 1981-07-10 | 1983-02-23 | Toyo Jozo Kk | Glutamic acid amides and use in assaying gamma -glutamyl transpeptidase |
| US4384041A (en) * | 1980-04-07 | 1983-05-17 | Toyo Jozo Kabushiki Kaisha | Assay method of enzyme activity |
| DE3331588A1 (en) * | 1982-09-01 | 1984-03-01 | Toyo Jozo K.K., Tagata, Shizuoka | AMID COMPOUNDS |
| EP0108526A2 (en) * | 1982-11-01 | 1984-05-16 | Beckman Instruments, Inc. | Method and reagent for the determination of peroxide and precursors thereof |
| US4472499A (en) * | 1982-01-22 | 1984-09-18 | American Hoechst Corporation | Reagents for the determination of enzymes |
| US4529709A (en) * | 1982-05-14 | 1985-07-16 | Nitto Boseki Co. Ltd. | Method for determination of 5-aminosalicylic acid |
-
1988
- 1988-06-06 US US07/203,071 patent/USRE33635E/en not_active Expired - Lifetime
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4177109A (en) * | 1977-05-30 | 1979-12-04 | Wako Pure Chemical Industries, Ltd. | γ-glutamyl-p-aminoanilide derivatives for measuring activity of γ-glutamyl transpeptidase |
| US4209459A (en) * | 1978-06-01 | 1980-06-24 | Nitto Boseki Co., Ltd. | Novel L-leucyl-4-hydroxyanilide derivatives |
| US4384041A (en) * | 1980-04-07 | 1983-05-17 | Toyo Jozo Kabushiki Kaisha | Assay method of enzyme activity |
| GB2103607A (en) * | 1981-07-10 | 1983-02-23 | Toyo Jozo Kk | Glutamic acid amides and use in assaying gamma -glutamyl transpeptidase |
| US4472499A (en) * | 1982-01-22 | 1984-09-18 | American Hoechst Corporation | Reagents for the determination of enzymes |
| US4472499B1 (en) * | 1982-01-22 | 1988-11-08 | ||
| US4529709A (en) * | 1982-05-14 | 1985-07-16 | Nitto Boseki Co. Ltd. | Method for determination of 5-aminosalicylic acid |
| DE3331588A1 (en) * | 1982-09-01 | 1984-03-01 | Toyo Jozo K.K., Tagata, Shizuoka | AMID COMPOUNDS |
| EP0108526A2 (en) * | 1982-11-01 | 1984-05-16 | Beckman Instruments, Inc. | Method and reagent for the determination of peroxide and precursors thereof |
Non-Patent Citations (2)
| Title |
|---|
| Lin et al., J. Agric. Food Chem., 1981, 29, 253 257. * |
| Lin et al., J. Agric. Food Chem., 1981, 29, 253-257. |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6624147B1 (en) * | 1999-09-28 | 2003-09-23 | Rijksuniversiteit Leiden | Inhibitors of prenylated pyrophosphate consuming enzymes |
| CN115992198A (en) * | 2022-11-14 | 2023-04-21 | 青岛科技大学 | Method for measuring activity of dextranase and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4681841A (en) | Enzymatic assay method | |
| Zakowski et al. | Biochemistry of human alpha amylase isoenzymes | |
| Lojda | Indigogenic methods for glycosidases: II. An improved method for β-D-galactosidase and its application to localization studies of the enzymes in the intestine and in other tissues | |
| Koldovsky et al. | A method for the separate assay of “neutral” and “acid” β-galactosidase in homogenates of rat small-intestinal mucosa | |
| Fishman | Determination of ẞ-glucuronidases | |
| Lorentz et al. | Arylesterase in serum: elaboration and clinical application of a fixed-incubation method. | |
| JP3159451B2 (en) | Measurement of glycated protein | |
| Sylvén et al. | Studies on the histochemical “leucine aminopeptidase” reaction: I. Identity of the enzymes possibly involved | |
| Burlina et al. | Characteristics and behaviour of arylesterase in human serum and liver | |
| Lojda et al. | Synthetic substrates in the histochemical demonstration of intestinal disaccharidases | |
| Tietz | Support of the diagnosis of pancreatitis by enzyme tests—old problems, new techniques | |
| Hitomi et al. | A sensitive colorimetric assay for human urinary kallikrein | |
| EP0810290B1 (en) | Method for end pointing enzyme detection methods | |
| FR2555608A1 (en) | Method of enzymatic determination | |
| US4895799A (en) | Process and reagent for the determination of total bilirubin | |
| USRE33635E (en) | Enzymatic assay method | |
| JP4925384B2 (en) | Method for quantifying N-terminal glycated protein | |
| Glass et al. | Metabolism in marine flatfish—IV. Carbohydrate and protein digestion in Atlantic halibut (Hippoglossus hippoglossus L.) | |
| AU604211B2 (en) | Method of determining cystic fibrosis ciliostatic factor | |
| US5223404A (en) | Composition for testing periodontal diseases | |
| Danovitch et al. | Colonic mucosal lysosomal enzyme activities in ulcerative colitis | |
| Lojda et al. | Histochemical demonstration of the intestinal hetero-β-galactosidase (glucosidase) | |
| JPS6012040B2 (en) | Composition and method for detecting triglycerides | |
| US5350678A (en) | Method of differential assay for α-amylase isozymes and a kit for the same | |
| Den Tandt et al. | Deficiency of neuraminidase in the sialidoses and the mucolipidoses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FPAY | Fee payment |
Year of fee payment: 8 |